0001727255 2025-01-01 2025-12-31 0001727255 2025-06-30 0001727255 2026-03-31 0001727255 2025-12-31 0001727255 2024-12-31 0001727255 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001727255 us-gaap:SeriesAPreferredStockMember 2024-12-31 0001727255 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001727255 us-gaap:SeriesBPreferredStockMember 2024-12-31 0001727255 2024-01-01 2024-12-31 0001727255 us-gaap:PreferredStockMember 2023-12-31 0001727255 us-gaap:CommonStockMember 2023-12-31 0001727255 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001727255 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001727255 us-gaap:RetainedEarningsMember 2023-12-31 0001727255 2023-12-31 0001727255 us-gaap:PreferredStockMember 2024-12-31 0001727255 us-gaap:CommonStockMember 2024-12-31 0001727255 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001727255 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001727255 us-gaap:RetainedEarningsMember 2024-12-31 0001727255 us-gaap:PreferredStockMember 2024-01-01 2024-12-31 0001727255 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001727255 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001727255 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001727255 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001727255 us-gaap:PreferredStockMember 2025-01-01 2025-12-31 0001727255 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001727255 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-12-31 0001727255 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-12-31 0001727255 us-gaap:RetainedEarningsMember 2025-01-01 2025-12-31 0001727255 us-gaap:PreferredStockMember 2025-12-31 0001727255 us-gaap:CommonStockMember 2025-12-31 0001727255 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001727255 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001727255 us-gaap:RetainedEarningsMember 2025-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember 2025-01-01 2025-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember 2024-01-01 2024-12-31 0001727255 us-gaap:RestrictedStockMember 2025-01-01 2025-12-31 0001727255 us-gaap:RestrictedStockMember 2024-01-01 2024-12-31 0001727255 COBA:ExerciseOfStockOptionsMember 2025-01-01 2025-12-31 0001727255 COBA:ExerciseOfStockOptionsMember 2024-01-01 2024-12-31 0001727255 srt:MinimumMember 2025-12-31 0001727255 srt:MaximumMember 2025-12-31 0001727255 srt:MinimumMember us-gaap:LandBuildingsAndImprovementsMember 2025-12-31 0001727255 srt:MaximumMember us-gaap:LandBuildingsAndImprovementsMember 2025-12-31 0001727255 COBA:BaltrumMiningConcessionsMember 2025-12-31 0001727255 COBA:BaltrumMiningConcessionsMember 2024-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember 2024-12-26 0001727255 COBA:SeriesBConvertiblePreferredStockMember 2024-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember 2024-12-29 0001727255 COBA:SeriesBConvertiblePreferredIntoCommonStockMember COBA:SeriesBConvertiblePreferredStockMember 2025-01-01 2025-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember 2025-01-01 2025-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember COBA:CashReceivedMember 2025-01-01 2025-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember COBA:SubscriptionsReceivableMember 2025-01-01 2025-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember 2024-01-01 2024-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember COBA:CashReceivedMember 2024-01-01 2024-12-31 0001727255 COBA:SeriesBConvertiblePreferredStockMember COBA:SubscriptionsReceivableMember 2024-01-01 2024-12-31 0001727255 COBA:CobaltChileSpaMember 2025-01-01 2025-12-31 0001727255 COBA:MadesalSpAAndGlenoreMember 2025-01-01 2025-12-31 0001727255 COBA:VendorMember 2024-01-01 2024-12-31 0001727255 COBA:EquityIncentivePlan2022Member 2022-04-26 0001727255 COBA:EquityIncentivePlan2022Member 2025-12-31 0001727255 COBA:OfficersManagersAdvisorsAndDirectorsMember 2022-05-23 2022-05-24 0001727255 COBA:AnAdvisorMember 2022-05-30 2022-06-01 0001727255 COBA:AnOfficerMember 2022-07-14 2022-07-15 0001727255 COBA:OfficerAndDirectorMember 2022-07-27 2022-07-28 0001727255 COBA:EquityIncentivePlan2023Member 2023-06-29 0001727255 COBA:EquityIncentivePlan2023Member 2025-12-31 0001727255 COBA:OfficersManagementAndDirectorsMember 2023-06-28 2023-07-01 0001727255 COBA:DirectorsMember 2023-07-06 2023-07-07 0001727255 COBA:AdvisoryBoardMember 2024-01-24 2024-01-25 0001727255 COBA:AdvisoryBoardMember 2024-02-12 2024-02-13 0001727255 COBA:OfficersDirectorsAndAdvisoryBoardMember 2025-01-16 2025-01-17 0001727255 COBA:OfficersDirectorsAndAdvisoryBoardMember COBA:Vesting125GrantedSharesMember 2025-01-16 2025-01-17 0001727255 COBA:OfficersDirectorsAndContractorsMember 2025-01-01 2025-12-31 0001727255 COBA:OfficersDirectorsAndAdvisoryBoardMember COBA:Vesting25GrantedSharesMember 2025-01-16 2025-01-17 0001727255 COBA:AdvisoryBoardMember 2025-01-01 2025-12-31 0001727255 srt:DirectorMember 2025-07-28 2025-07-29 0001727255 COBA:EquityIncentivePlan2025Member 2025-07-24 0001727255 us-gaap:RestrictedStockUnitsRSUMember COBA:EquityIncentivePlan2025Member 2025-07-25 2025-12-31 0001727255 COBA:ADirectorMember us-gaap:RestrictedStockUnitsRSUMember COBA:EquityIncentivePlan2025Member 2025-08-27 2025-08-28 0001727255 COBA:StockOptionsMember 2025-01-01 2025-12-31 0001727255 COBA:StockOptionsMember 2024-01-01 2024-12-31 0001727255 COBA:StockOptionsMember 2025-12-31 0001727255 us-gaap:RestrictedStockUnitsRSUMember 2025-07-25 2025-12-31 0001727255 us-gaap:RestrictedStockUnitsRSUMember 2025-08-27 2025-08-28 0001727255 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-12-31 0001727255 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-12-31 0001727255 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001727255 srt:MinimumMember 2024-01-01 2024-12-31 0001727255 srt:MaximumMember 2024-01-01 2024-12-31 0001727255 srt:MinimumMember 2025-01-01 2025-12-31 0001727255 srt:MaximumMember 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedMay242022Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedMay242022Member 2025-12-31 0001727255 COBA:OptionsIssuedMay242022Member 2024-12-31 0001727255 COBA:OptionsIssuedMay242022Member 2024-01-01 2024-12-31 0001727255 COBA:OptionsIssuedJune012022Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedJune012022Member 2025-12-31 0001727255 COBA:OptionsIssuedJune012022Member 2024-12-31 0001727255 COBA:OptionsIssuedJune012022Member 2024-01-01 2024-12-31 0001727255 COBA:OptionsIssuedJuly152022Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedJuly152022Member 2025-12-31 0001727255 COBA:OptionsIssuedJuly152022Member 2024-12-31 0001727255 COBA:OptionsIssuedJuly152022Member 2024-01-01 2024-12-31 0001727255 COBA:OptionsIssuedJuly282022Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedJuly282022Member 2025-12-31 0001727255 COBA:OptionsIssuedJuly282022Member 2024-12-31 0001727255 COBA:OptionsIssuedJuly282022Member 2024-01-01 2024-12-31 0001727255 COBA:OptionsIssuedJuly012023Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedJuly012023Member 2025-12-31 0001727255 COBA:OptionsIssuedJuly012023Member 2024-12-31 0001727255 COBA:OptionsIssuedJuly012023Member 2024-01-01 2024-12-31 0001727255 COBA:OptionsIssuedJuly072023Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedJuly072023Member 2025-12-31 0001727255 COBA:OptionsIssuedJuly072023Member 2024-12-31 0001727255 COBA:OptionsIssuedJuly072023Member 2024-01-01 2024-12-31 0001727255 COBA:OptionsIssuedJan252024Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedJan252024Member 2025-12-31 0001727255 COBA:OptionsIssuedJan252024Member 2024-12-31 0001727255 COBA:OptionsIssuedJan252024Member 2024-01-01 2024-12-31 0001727255 COBA:OptionsIssuedFeb132024Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedFeb132024Member 2025-12-31 0001727255 COBA:OptionsIssuedFeb132024Member 2024-12-31 0001727255 COBA:OptionsIssuedFeb132024Member 2024-01-01 2024-12-31 0001727255 COBA:OptionsIssuedJan172025Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedJan172025Member 2025-12-31 0001727255 COBA:OptionsIssuedJan172025Member 2024-12-31 0001727255 COBA:OptionsIssuedJuly292025Member 2025-01-01 2025-12-31 0001727255 COBA:OptionsIssuedJuly292025Member 2025-12-31 0001727255 COBA:OptionsIssuedJuly292025Member 2024-12-31 0001727255 COBA:ChileanCobaltMember 2025-01-01 2025-12-31 0001727255 COBA:BaltumMember 2025-01-01 2025-12-31 0001727255 COBA:ChileanCobaltMember 2024-01-01 2024-12-31 0001727255 COBA:BaltumMember 2024-01-01 2024-12-31 0001727255 us-gaap:RestrictedStockUnitsRSUMember COBA:AshLazenbyMember 2025-12-31 0001727255 us-gaap:EmployeeStockOptionMember COBA:DuncanBlountMember 2025-05-07 0001727255 us-gaap:EmployeeStockOptionMember COBA:JimVanHornMember 2025-05-07 0001727255 us-gaap:EmployeeStockOptionMember COBA:JeremyMcCannMember 2025-05-07 iso4217:USD shares iso4217:USD shares pure COBA:Integer false 2025 FY 0001727255

10-K true 2025-12-31 --12-31 false 333-268335 CHILEAN COBALT CORP. NV 82-3590294 1199 Lancaster Ave Suite 107 Berwyn PA 19312 484 580-8697 No No No Yes Non-accelerated Filer true true false false false false 16371627 56409930 Cybersecurity Risk Management and Strategy We recognize the importance of assessing, identifying, and managing material risks associated with cybersecurity threats, as such term is defined in Item 106(a) of Regulation S-K. These risks include, among other things: operational risks, intellectual property theft, fraud, extortion, harm to employees or customers and violation of data privacy or security laws. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20250101__20251231_zuyVwjxhkOK7">We use a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20250101__20251231_zeLy91biOnsg">third-party vendor to provide a suite of services to assess, identify, and manage material risks from cybersecurity threats. These services include providing us with a secure email platform, including content examination and data leak prevention; system monitoring and support, including patch management, anti-virus and threat hunting services; and system backup and recovery services. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_909_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20250101__20251231_zR7n0Nm9tob9">As we expand our business operations, we plan to evaluate the development of enhanced processes that will allow for the identification and assessment of cybersecurity risk that will be <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_zJk0xPBLqOB3">integrated into an overall risk management system, which will be managed by senior management and overseen by the Board of Directors. As part of these developments, we plan to identify and address cybersecurity risks related to our business, privacy and compliance issues through a multi-faceted approach that is expected to include third-party assessments, internal information technology (IT) audit, IT security, governance, risk and compliance reviews. In connection with these planned approaches, and to defend, detect and respond to cybersecurity incidents, we, among other things, will consider: conducting proactive privacy and cybersecurity reviews of systems and applications, audits of applicable data policies, performing penetration testing using external third-party tools and techniques to test security controls, conducting employee training, monitoring emerging laws and regulations related to data protection and information security, and implementing appropriate changes. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_900_ecyd--CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_c20250101__20251231_zSSGLyjVGL48">As part of the above-planned processes, we may engage external auditors and consultants with expertise in cybersecurity to assess our internal cybersecurity programs and compliance with applicable practices and standards. We plan to design our risk management program to also assess third-party risks, and we plan to perform third-party risk management to identify and mitigate risks from third parties, such as vendors, suppliers, and other business partners associated with our use of third-party service providers. In addition to new vendor onboarding, we plan to perform risk management during third-party cybersecurity compromise incidents to identify and mitigate risks to us from third-party incidents. true true As we expand our business operations, we plan to evaluate the development of enhanced processes that will allow for the identification and assessment of cybersecurity risk that will be <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_zJk0xPBLqOB3">integrated into an overall risk management system, which will be managed by senior management and overseen by the Board of Directors. true As part of the above-planned processes, we may engage external auditors and consultants with expertise in cybersecurity to assess our internal cybersecurity programs and compliance with applicable practices and standards. Cybersecurity Governance <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20250101__20251231_zMulDBmsPDa6">We expect that cybersecurity will become an important part of our risk management processes and an area of focus for our Board of Directors and management. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_900_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zXDrd4Px4yQl">We expect that our Board of Directors will be responsible for the oversight of risks from cybersecurity threats. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zxJBNPx9Vk47">We expect our senior management will provide our Board of Directors updates on at least an annual basis regarding matters of cybersecurity. This is expected to include existing and new cybersecurity risks, status on how management is addressing and/or mitigating those risks, cybersecurity and data privacy incidents (if any) and status on key information security initiatives. We expect that our Board members will also engage in periodic conversations with management on cybersecurity-related news events and discuss any updates to our cybersecurity risk management and strategy programs. Currently, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20250101__20251231_zk3NWKEH7k5f">our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250101__20251231_zcNQ2KiMtdYe">Chief Operating Officer is expected to lead our cybersecurity risk assessment and management processes and oversee their implementation and maintenance. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20250101__20251231_z10NzLOVWci8">Our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_900_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbT_c20250101__20251231_zpvuy3YXc0q5">Chief Operating Officer will be tasked with staying informed about, and monitoring the prevention, mitigation, detection and remediation of cybersecurity incidents through his management of, and participation in, the cybersecurity risk management and strategy processes we plan to develop and as described above, including the operation of an incident response plan, and report to the Board of Directors on any appropriate items. We expect that cybersecurity will become an important part of our risk management processes and an area of focus for our Board of Directors and management. We expect that our Board of Directors will be responsible for the oversight of risks from cybersecurity threats. We expect our senior management will provide our Board of Directors updates on at least an annual basis regarding matters of cybersecurity. our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250101__20251231_zcNQ2KiMtdYe">Chief Operating Officer is expected to lead our cybersecurity risk assessment and management processes and oversee their implementation and maintenance. true Our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_900_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbT_c20250101__20251231_zpvuy3YXc0q5">Chief Operating Officer will be tasked with staying informed about, and monitoring the prevention, mitigation, detection and remediation of cybersecurity incidents through his management of, and participation in, the cybersecurity risk management and strategy processes we plan to develop and as described above, including the operation of an incident response plan, and report to the Board of Directors on any appropriate items. true Fruci & Associates II, PLLC 5525 Spokane, Washington

2772082

331309

73431

72231

64416

2844313

469156

2958

2847271

472114

35388

18128

15044

16441

50432

34569

50432

34569

0.0001

19848875

0.0001

2900000

724420

0.0001

100000000

56409930

43502145

5641

4350

39191565

33565165

245585

250770

-36645952

-33382812

2796839

437545

2847271

472114

81738

1318937

900147

-4499

1142

1405174

899005

-1405174

-899005

358

23116

16073

1881082 -0

-3263140

-882574

-3263140

-882574

-0.07

-0.02

45370385

43456021

-3263140

-882574

-5185

-2717

-3268325

-885291

43285716

4329

33081263

253487

-32500238

838841

724420

325917

325989

-2717

216429

157979

158000

-882574

724420

43502145

4350

33565165

250770

-33382812

437545

724420

43502145

4350

33565165

250770

-33382812

437545

1683365

169

757345

757514

-2407785 -241 2407785 241

6000000

600

2751900

2752500

4500000 450 1889550 1890000

-5185

227605

-3263140

56409930

5641

39191565

245585

-36645952

2796839

-3263140

-882574

1881082

227605

158000

7815

7414

15795

13713

-1146473

-718275

830945

252558

2752500

3583445

252564

3801

-2851

2440773

-468562

331309

799871

2772082

331309

1890000 0 1083503 0

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">1.</td> <td>Organization and Nature of Business</td></tr> </table> The accompanying consolidated financial statements include the accounts of Chilean Cobalt Corp. (the “Company”) (OTCQB: COBA), a Nevada corporation formed on December 4, 2017, and its wholly-owned subsidiary Baltum Minería SpA (“Baltum”), a Chilean Sociedad por Acciones formed on January 3, 2018. The Company is a cobalt and copper, junior mining and exploration company and also has an earn-in option to potentially acquire royalties or concessions in rare earth element mining concessions. Cobalt, a critical mineral for many of the current cathode battery chemistry configuration options in the electric vehicle (“EV”) battery production space, was mined in Chile for 100 years from 1844 thru 1944 and ceased at the end of World War II. Baltum owns exploitation-level mining concessions for 6,377 hectares in the San Juan Mining District in northern Chile. On May 12, 2022, the former Parent Company, Genlith, Inc. distributed all of its shares in the Company to its individual shareholders. As of the date of the distribution, Genlith, Inc. no longer held an equity interest in the Company. The Company’s year-end is December 31.

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">2.</td> <td>Going Concern</td></tr> </table> The Company has not yet begun to generate revenue as of December 31, 2025, has incurred recurring losses since inception, and expects to continue to incur losses as a result of costs and expenses related to mining exploration and general and administrative expenses. For the year ended December 31, 2025, the Company reported a net loss of $3,263,140, however, $1,881,082 was related to a one-time, non-cash charge for impairment of mining concessions, and had an accumulated deficit of $36,645,952. The ability of the Company to continue as a going concern over a longer term is dependent on the Company’s ability to raise the financing necessary to complete the exploration and development of cobalt and copper mines and bring mining operations into production and commercialization. Furthermore, the Company’s ability to achieve the milestones required to earn rare earth element mining concession royalties or ownership is also dependent on the Company’s ability to raise the necessary financing. With a cash balance of $2,772,082 as of December 31, 2025, the Company is well positioned to further its strategic objectives, but depending on the pace of project development and success in raising capital, may not have sufficient financial resources to continue its operations for the next 12 months, in spite of the existing cash balance. Historically the Company has funded its operations with the private placement of equity, debt, and related party loans. However, raising capital sufficient to continue exploration and bring the Company into production and commercialization is dependent on continued discussions with potential off-take partners, debt providers, alternative lenders and investors and is a material uncertainty. There can be no assurance as to the availability or terms upon which such financing or capital might be available. As a result of these factors, there is substantial doubt about the Company’s ability to continue as a going concern.

-3263140

1881082

-36645952

2772082

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">3.</td> <td>Summary of Significant Accounting Policies Basis of Presentation</td></tr> </table> The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The financial statements include the consolidated accounts of the Company and its wholly-owned subsidiary Baltum Minería SpA. All material intercompany transactions have been eliminated in consolidation. The Company has reclassified certain amounts in the 2024 financial statements to comply with the 2025 presentation. These principally relate to classification of certain expenses and liabilities. The reclassifications had no impact on total net loss or net cash flows for the year ended December 31, 2024. Earnings (Loss) Per Share The weighted-average common shares outstanding for both basic and diluted earnings per share for all periods presented was calculated, in accordance with the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) 260, Earnings Per Share. To the extent that stock options, warrants and convertible preferred stock are anti-dilutive, they are excluded from the calculation of diluted earnings (loss) per share. For the years ended December 31, 2025 and 2024, the Company excluded the following shares from the calculation of diluted loss per share because such amounts were anti-dilutive: <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zNO4g1eFpFqe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies Basis of Presentation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of anti-dilutive shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Shares issuable upon conversion of Series B Convertible Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBConvertiblePreferredStockMember_zc7yIJR90Hqe" style="width: 13%; text-align: right" title="Antidilutive shares">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBConvertiblePreferredStockMember_z7yNmazXnLuf" style="width: 13%; text-align: right" title="Antidilutive shares">724,420</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shares issuable upon vesting of Restricted Stock Units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zGrNrR8iPvT9" style="text-align: right" title="Antidilutive shares">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zfL5cDms3lxj" style="text-align: right" title="Antidilutive shares">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Shares issuable upon exercise of stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ExerciseOfStockOptionsMember_z4heGp7tUcN8" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">7,177,504</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ExerciseOfStockOptionsMember_zKdAUazBn5w9" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">6,420,629</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231_zeRKpjALa6Ec" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">7,677,504</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231_zvka0zd5Eqd5" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">7,145,349</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Fair Value Measurements The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities, as necessary, and to determine fair value disclosures of financial instruments on a recurring basis. Consistent with ASC Topic 820, Fair Value Measurements (“ASC 820”), assets and liabilities that are required to be recorded at fair value are done so at the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. When measuring fair value, and consistent with the fair value hierarchy in ASC 820, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs consistent with the following fair value hierarchy: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify">Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Level 3 inputs are unobservable inputs for the asset or liability.</td></tr> </table> For assets and liabilities measured at fair value when there is limited or no observable market data, management applies judgment to estimate fair value and considers factors such as current pricing policy, the economic and competitive environment, the characteristics of the asset or liability, and other factors. The amounts estimated by management cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the asset or liability. Inherent limitations in any such fair value calculation technique, including changes in discount rates, estimates of future cash flows, and other underlying assumptions, could significantly affect the results of current or future value. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to the applicability of accrued expenses and volatility used in the determination of stock-based expenses. Estimates are periodically reviewed in light of changes in circumstances, facts, and experience. There have been no changes in estimates during the periods presented. Actual results could differ from the Company’s estimates and those differences may be material. Cash Cash amounts consist of cash on hand, bank deposits, and money market accounts. Cash equivalents consist of all liquid debt instruments with original maturities of three months or less. As of December 31, 2025, and December 31, 2024, the Company’s cash balances were $2,772,082 and $331,309, respectively, and the Company’s cash equivalents were $-0- and $-0-, respectively. Subscriptions Receivable and Stock Compensation The Company typically reflects subscriptions receivable in stockholders’s equity, unless there is substantial evidence of the intent and ability of the subscriber to pay the amounts in a reasonable amount of time, in which case the subscriptions receivable are instead reflected as an asset on the balance sheet. The subscriptions receivable of $73,431 was reflected as an asset on the balance sheet as of December 31, 2024, as the amounts were received from the subscribers within days after year-end, which was considered substantial evidence of the intent and ability of the subscribers to pay the amounts in a reasonable amount of time. The Company reflects stock-based compensation at the intrinsic value of the compensation ratably across the periods in which the compensation is earned. When stock is issued for services, the intrinsic value of the stock issued is amortized ratably over the period in which the compensation is earned. In the initial period of amortization, the amortized portion is reflected in preferred or common stock, as applicable, for both shares and the full par value with any residual reflected in additional paid-in capital. The amortization for each subsequent period is reflected entirely in additional paid-in capital. Value Added Tax (“VAT Tax”) The Company’s subsidiary historically has paid significant amounts of value-added tax (“VAT Tax”) to the Chilean government on certain operating purchases. The tax paid can be offset against future VAT Tax due. The Company has not recorded any VAT tax receivables as of December 31, 2025, and December 31, 2024, because the Company’s ability to engage in sales activity necessary to recover VAT taxes paid in on its expenditures, is currently indeterminable. Property and Equipment Property, plant, and equipment are stated at cost, less accumulated depreciation. Acquired property, plant and equipment are recognized at their estimated fair value. Capitalized costs may include computers, vehicles, furniture and fixtures, machinery, and equipment, and are depreciated using the straight-line method or unit-of-production method at rates sufficient to depreciate such costs over the shorter of estimated productive lives or the useful life of the individual assets. Useful lives range from 3 to 10 years. Capitalized costs may also include buildings or improvements to land, which if applicable, have useful lives ranging from <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandBuildingsAndImprovementsMember__srt--RangeAxis__srt--MinimumMember_zOniOEdfX5uh" title="Property and equipment useful lives">20 to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandBuildingsAndImprovementsMember__srt--RangeAxis__srt--MaximumMember_zodp2xLP0hUc" title="Property and equipment useful lives">40 years. Gains and losses are reflected in income or expense upon sale or retirement of assets. Expenditures that extend the useful lives of property, plant and equipment or increase productivity are capitalized. Ordinary repairs and maintenance are expensed as incurred through operating expense. We periodically evaluate whether events or circumstances indicate that the net book value of our property, plant and equipment may not be recoverable. Costs are capitalized when it has been determined an ore body can be economically developed. The development stage begins at new projects when our management and/or board of directors make the decision to bring a mine into commercial production and ends when the production state, or extraction of reserves, begins. The production stage of a mine commences when salable materials, beyond a de minimis amount, are produced. Exploration costs include those relating to activities carried out (a) in search of previously unidentified mineral deposits or (b) at undeveloped concessions. Pre-development activities involve costs incurred in the exploration stage that may ultimately benefit production and are expensed due to a lack of evidence of economic development, which is necessary to demonstrate future recoverability of these expenses. Costs for exploration, evaluation, and pre-development, including drilling costs related to those activities (discussed further below), and repairs and maintenance on capitalized property and equipment are charged to operations as incurred. Drilling, development, and related costs are either classified as exploration, pre-development or secondary development as defined above, and charged to operations as incurred, or capitalized based on the following criteria: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify">whether the costs are incurred to further define mineralization at and adjacent to existing reserve areas or intended to assist with mine planning within a reserved area;</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">whether the drilling or development costs relate to an ore body that has been determined to be commercially mineable, and a decision has been made to put the ore body into commercial production;</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">whether, at the time the cost is incurred: (a) the expenditure embodies a probable future benefit that involves a capacity, singly or in combination with other assets, to contribute directly or indirectly to future net cash inflows, (b) we can obtain the benefit and control others’ access to it, and (c) the transaction or event giving risk to our right to or control of the benefit has already occurred.</td></tr> </table> If all of these criteria are met, drilling, development and related costs are capitalized. Drilling and development costs not meeting all of these criteria are expensed as incurred. The following factors are considered in determining whether or not the criteria listed above have been met, and whether capitalization of drilling and development costs is appropriate: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td>Completion of a favorable economic study and mine plan for the ore body targeted;</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td>authorization of development of the ore body by management and/or the board of directors; and</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">there is a justifiable expectation, based on applicable laws and regulations, that issuance of permits or resolution of legal issues and/or contractual requirements necessary for us to have the right to or control of the future benefit from the targeted ore body have been met.</td></tr> </table> Drilling and related costs at our properties as of and for the years ended December 31, 2025, and December 31, 2024, respectively, did not meet our criteria for capitalization. When assets are retired or sold, the costs and related allowances for depreciation and amortization are eliminated from the accounts and any resulting gain or loss is reflected in the current period net income (loss). Impairment of Long-lived Assets Long-lived assets consist of property and equipment. Long-lived assets to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use and eventual disposition of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value less cost to sell or dispose, determined based on discounted cash flows. During the years ended December 31, 2025 and 2024, we recorded $1,881,082 and $-0-, respectively, impairment loss in those periods. The decision to write-down the mining concessions acquired on September 12, 2025 was driven by the lack of reliability of and availability of independent valuations for these unique assets, as necessary to substantiate their value on these financial statements. Baltum presently owns 6,377 hectares of exploitation-level mining concessions in the San Juan mining district, which were recorded as fully impaired and written down to $-0- value from approximately $10.7 million on the Company’s facilities located in the San Juan mining district of Chile. Under a funding level that allows the Company to focus on exploration, Baltum will continue its exploration activities under these mining concessions toward proving the existence of cobalt and/or copper. Depending on the outcome of the exploration activities, the Company would then consider seeking a preliminary economic assessment, preliminary feasibility study, or definitive feasibility study to validate the expected profitability of constructing a plant to extract the target minerals and process them into saleable products. Environmental Obligations We provide for environmental-related obligations when they are probable and amounts can be reasonably estimated. Where the available information is sufficient to estimate the amount of liability, that estimate has been used. Included in environmental liabilities are costs for the operation, maintenance and monitoring of site remediation plans (“OM&M”). If applicable, such reserves are based on our best estimates for these OM&M plans. Over time we could incur OM&M costs in excess of these reserves. However, we are unable to reasonably estimate an amount in excess of any recorded reserves because we cannot reasonably estimate the period for which such OM&M plans will need to be in place or the future annual cost of such remediation, as conditions at environmental sites change over time. If applicable, such additional OM&M costs could be significant in total but would be incurred over an extended period of years. Environmental remediation charges represent the costs for continuing charges associated with environmental remediation at operating sites from previous years and from products that are no longer manufactured and are currently not applicable. Leases The Company determines if an arrangement is a lease at the inception of the contract. If applicable, our operating leases are included in Operating lease right-of-use (“ROU”) assets, operating lease liabilities – current, and Operating lease liabilities – long term in the consolidated balance sheets. The operating lease ROU assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit interest rate, we utilize an estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. In determining the discount rate used in the present value calculation, the Company has elected to apply the portfolio approach for leases provided the leases commenced at or around the same time. This election allows the Company to account for leases at a portfolio level provided that the resulting accounting at this level would not differ materially from the accounting at the individual lease level. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. If leases are applicable, the Company has elected not to separate lease and non-lease components and accounts for each separate lease component and non-lease component associated with that lease component as a single lease component. Operating lease ROU assets include all contractual lease payments and initial direct costs incurred less any lease incentives. Facility leases generally only contain lease expense and non-component items such as taxes and pass-through charges. Additionally, we have elected not to apply the recognition requirements of ASC 842 to leases which have a lease term of less than one year at the commencement date. Mining Concessions Mining concessions are recorded at cost based on the payments required under the contracts. Amortization begins when placed in service after the mining concession is exercised. Mining concessions are amortized over their useful life based on the pattern over which the mining concessions are consumed or otherwise used up. Determination of expected useful lives for amortization calculations is made on a property-by-property or asset-by-asset basis at least annually. At the time an ore body can be economically developed, the basis of the mining concession will be amortized on a units-of-production basis. Pursuant to our policy on the impairment of long-lived assets, if it is determined that a mining concession cannot be economically developed or its innate value has not been independently substantiated, the basis of the mining concession is reduced to its fair value and an impairment loss is recorded to expense in the period in which it is determined to be impaired. Finite-lived intangible assets are tested for impairment when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. Intangible assets that are not subject to amortization are tested for impairment annually and more frequently if events or changes in circumstances indicate that is more likely than not, meaning more than 50%, that the asset is impaired. The value of the exploitation mining concessions owned by Baltum has yet to be independently substantiated by a valuation or any level of feasibility study. As of December 31, 2025, and December 31, 2024, these mining concessions had a value of $-0- and $-0-, respectively on the Company’s consolidated balance sheet. Restructuring and Other Charges We continually perform strategic reviews and assess the returns on our businesses. In the event that this results in a plan to restructure the operations of our business, we record an accrual for severance and other exit costs under the provisions of the relevant accounting guidance. Research and Development Research and development costs are expensed as incurred. Foreign Currency The reporting currency of the Company is the U.S. dollar. The functional currency of Baltum, the Company’s wholly-owned subsidiary, is the Chilean Peso. The assets and liabilities of Baltum are translated into U.S. dollars based on exchange rates at the end of each reporting period. Expenses are translated at average exchange rates during the reporting period. Gains and losses arising from the translation of assets and liabilities are included as a component of accumulated other comprehensive income or loss within the Company’s consolidated balance sheet. Gains and losses resulting from foreign currency transactions are reflected within the Company’s consolidated statements of operations. Transactions denominated in foreign currency other than our functional currency of the foreign operation are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are remeasured at each reporting date into the functional currency at the exchange rate at that date. The Company has not utilized foreign currency hedging strategies to mitigate the effect of its foreign currency exposure. We recorded transaction and remeasurement gains of $-0.0- million and $-0.0- million for the years ended December 31, 2024 and 2025, respectively. Income Taxes The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company’s tax returns. Deferred taxes are determined based on the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. The potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. The Company’s wholly owned subsidiary is subject to foreign corporate tax in foreign taxing jurisdictions. We do not provide income taxes on the equity in undistributed earnings of consolidated foreign subsidiaries as it is our intention that such earnings will remain invested in those companies. The Company accounts for income taxes in accordance with ASC 740, “Accounting for Income Taxes” (“ASC 740”). Under ASC 740, income tax expense includes federal and state taxes currently payable and deferred taxes arising from temporary differences between income for financial reporting and income tax purposes. In accordance with ASC 740, the Company has evaluated its tax positions. A tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that has a likelihood of being realized on examination of more than 50 percent. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. Under the “more likely than not” threshold guidelines, the Company believes no significant uncertain tax positions exist, either individually or in the aggregate, that would give rise to the non-recognition of an existing tax benefit. The Company’s policy is to account for interest expense and penalties related to unrecognized tax benefits as a component of income tax expense. The Company is currently not under examination with any federal, state, or foreign taxing authorities. In addition, the Company had no material unrecognized tax benefits or accrued interest and penalties as of and for the year ended December 31, 2025. Concentration of Credit Risk and of Significant Vendors The Company maintains cash balances at financial institutions in the U.S. and Chile. The Company holds all cash balances at accredited financial institutions, in amounts that exceed federally insured limits in the United States of America. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. Segment Reporting The Company has not yet begun generating revenues from its planned principal operations and operates as a single reportable segment for its mining projects in Chile. The chief operating decision maker is the Company’s chief executive officer, who assesses the performance based on total expenses, cash flows and progress made in the Company’s ongoing development efforts. All of the Company’s long-lived assets are located in Chile. Recently Issued and Adopted Accounting Pronouncements The Company’s management has evaluated all the recently issued accounting pronouncements through the filing date of these financial statements, including ASC 2023-09, and does not believe that any of these pronouncements will have a material impact on the Company’s current financial position and results of operations.

Earnings (Loss) Per Share The weighted-average common shares outstanding for both basic and diluted earnings per share for all periods presented was calculated, in accordance with the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) 260, Earnings Per Share. To the extent that stock options, warrants and convertible preferred stock are anti-dilutive, they are excluded from the calculation of diluted earnings (loss) per share. For the years ended December 31, 2025 and 2024, the Company excluded the following shares from the calculation of diluted loss per share because such amounts were anti-dilutive: <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zNO4g1eFpFqe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies Basis of Presentation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of anti-dilutive shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Shares issuable upon conversion of Series B Convertible Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBConvertiblePreferredStockMember_zc7yIJR90Hqe" style="width: 13%; text-align: right" title="Antidilutive shares">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBConvertiblePreferredStockMember_z7yNmazXnLuf" style="width: 13%; text-align: right" title="Antidilutive shares">724,420</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shares issuable upon vesting of Restricted Stock Units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zGrNrR8iPvT9" style="text-align: right" title="Antidilutive shares">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zfL5cDms3lxj" style="text-align: right" title="Antidilutive shares">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Shares issuable upon exercise of stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ExerciseOfStockOptionsMember_z4heGp7tUcN8" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">7,177,504</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ExerciseOfStockOptionsMember_zKdAUazBn5w9" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">6,420,629</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231_zeRKpjALa6Ec" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">7,677,504</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231_zvka0zd5Eqd5" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">7,145,349</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zNO4g1eFpFqe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies Basis of Presentation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of anti-dilutive shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Shares issuable upon conversion of Series B Convertible Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBConvertiblePreferredStockMember_zc7yIJR90Hqe" style="width: 13%; text-align: right" title="Antidilutive shares">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBConvertiblePreferredStockMember_z7yNmazXnLuf" style="width: 13%; text-align: right" title="Antidilutive shares">724,420</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shares issuable upon vesting of Restricted Stock Units</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zGrNrR8iPvT9" style="text-align: right" title="Antidilutive shares">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zfL5cDms3lxj" style="text-align: right" title="Antidilutive shares">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Shares issuable upon exercise of stock options</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ExerciseOfStockOptionsMember_z4heGp7tUcN8" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">7,177,504</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ExerciseOfStockOptionsMember_zKdAUazBn5w9" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">6,420,629</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231_zeRKpjALa6Ec" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">7,677,504</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231_zvka0zd5Eqd5" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">7,145,349</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

724420

500000

7177504

6420629

7677504

7145349

Fair Value Measurements The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities, as necessary, and to determine fair value disclosures of financial instruments on a recurring basis. Consistent with ASC Topic 820, Fair Value Measurements (“ASC 820”), assets and liabilities that are required to be recorded at fair value are done so at the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. When measuring fair value, and consistent with the fair value hierarchy in ASC 820, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs consistent with the following fair value hierarchy: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify">Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Level 3 inputs are unobservable inputs for the asset or liability.</td></tr> </table> For assets and liabilities measured at fair value when there is limited or no observable market data, management applies judgment to estimate fair value and considers factors such as current pricing policy, the economic and competitive environment, the characteristics of the asset or liability, and other factors. The amounts estimated by management cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the asset or liability. Inherent limitations in any such fair value calculation technique, including changes in discount rates, estimates of future cash flows, and other underlying assumptions, could significantly affect the results of current or future value.

Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to the applicability of accrued expenses and volatility used in the determination of stock-based expenses. Estimates are periodically reviewed in light of changes in circumstances, facts, and experience. There have been no changes in estimates during the periods presented. Actual results could differ from the Company’s estimates and those differences may be material.

Cash Cash amounts consist of cash on hand, bank deposits, and money market accounts. Cash equivalents consist of all liquid debt instruments with original maturities of three months or less. As of December 31, 2025, and December 31, 2024, the Company’s cash balances were $2,772,082 and $331,309, respectively, and the Company’s cash equivalents were $-0- and $-0-, respectively.

2772082

331309

Subscriptions Receivable and Stock Compensation The Company typically reflects subscriptions receivable in stockholders’s equity, unless there is substantial evidence of the intent and ability of the subscriber to pay the amounts in a reasonable amount of time, in which case the subscriptions receivable are instead reflected as an asset on the balance sheet. The subscriptions receivable of $73,431 was reflected as an asset on the balance sheet as of December 31, 2024, as the amounts were received from the subscribers within days after year-end, which was considered substantial evidence of the intent and ability of the subscribers to pay the amounts in a reasonable amount of time. The Company reflects stock-based compensation at the intrinsic value of the compensation ratably across the periods in which the compensation is earned. When stock is issued for services, the intrinsic value of the stock issued is amortized ratably over the period in which the compensation is earned. In the initial period of amortization, the amortized portion is reflected in preferred or common stock, as applicable, for both shares and the full par value with any residual reflected in additional paid-in capital. The amortization for each subsequent period is reflected entirely in additional paid-in capital.

73431

Value Added Tax (“VAT Tax”) The Company’s subsidiary historically has paid significant amounts of value-added tax (“VAT Tax”) to the Chilean government on certain operating purchases. The tax paid can be offset against future VAT Tax due. The Company has not recorded any VAT tax receivables as of December 31, 2025, and December 31, 2024, because the Company’s ability to engage in sales activity necessary to recover VAT taxes paid in on its expenditures, is currently indeterminable.

Property and Equipment Property, plant, and equipment are stated at cost, less accumulated depreciation. Acquired property, plant and equipment are recognized at their estimated fair value. Capitalized costs may include computers, vehicles, furniture and fixtures, machinery, and equipment, and are depreciated using the straight-line method or unit-of-production method at rates sufficient to depreciate such costs over the shorter of estimated productive lives or the useful life of the individual assets. Useful lives range from 3 to 10 years. Capitalized costs may also include buildings or improvements to land, which if applicable, have useful lives ranging from <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandBuildingsAndImprovementsMember__srt--RangeAxis__srt--MinimumMember_zOniOEdfX5uh" title="Property and equipment useful lives">20 to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandBuildingsAndImprovementsMember__srt--RangeAxis__srt--MaximumMember_zodp2xLP0hUc" title="Property and equipment useful lives">40 years. Gains and losses are reflected in income or expense upon sale or retirement of assets. Expenditures that extend the useful lives of property, plant and equipment or increase productivity are capitalized. Ordinary repairs and maintenance are expensed as incurred through operating expense. We periodically evaluate whether events or circumstances indicate that the net book value of our property, plant and equipment may not be recoverable. Costs are capitalized when it has been determined an ore body can be economically developed. The development stage begins at new projects when our management and/or board of directors make the decision to bring a mine into commercial production and ends when the production state, or extraction of reserves, begins. The production stage of a mine commences when salable materials, beyond a de minimis amount, are produced. Exploration costs include those relating to activities carried out (a) in search of previously unidentified mineral deposits or (b) at undeveloped concessions. Pre-development activities involve costs incurred in the exploration stage that may ultimately benefit production and are expensed due to a lack of evidence of economic development, which is necessary to demonstrate future recoverability of these expenses. Costs for exploration, evaluation, and pre-development, including drilling costs related to those activities (discussed further below), and repairs and maintenance on capitalized property and equipment are charged to operations as incurred. Drilling, development, and related costs are either classified as exploration, pre-development or secondary development as defined above, and charged to operations as incurred, or capitalized based on the following criteria: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify">whether the costs are incurred to further define mineralization at and adjacent to existing reserve areas or intended to assist with mine planning within a reserved area;</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">whether the drilling or development costs relate to an ore body that has been determined to be commercially mineable, and a decision has been made to put the ore body into commercial production;</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">whether, at the time the cost is incurred: (a) the expenditure embodies a probable future benefit that involves a capacity, singly or in combination with other assets, to contribute directly or indirectly to future net cash inflows, (b) we can obtain the benefit and control others’ access to it, and (c) the transaction or event giving risk to our right to or control of the benefit has already occurred.</td></tr> </table> If all of these criteria are met, drilling, development and related costs are capitalized. Drilling and development costs not meeting all of these criteria are expensed as incurred. The following factors are considered in determining whether or not the criteria listed above have been met, and whether capitalization of drilling and development costs is appropriate: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td>Completion of a favorable economic study and mine plan for the ore body targeted;</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td>authorization of development of the ore body by management and/or the board of directors; and</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">there is a justifiable expectation, based on applicable laws and regulations, that issuance of permits or resolution of legal issues and/or contractual requirements necessary for us to have the right to or control of the future benefit from the targeted ore body have been met.</td></tr> </table> Drilling and related costs at our properties as of and for the years ended December 31, 2025, and December 31, 2024, respectively, did not meet our criteria for capitalization. When assets are retired or sold, the costs and related allowances for depreciation and amortization are eliminated from the accounts and any resulting gain or loss is reflected in the current period net income (loss).

P3Y

P10Y

P20Y

P40Y

Impairment of Long-lived Assets Long-lived assets consist of property and equipment. Long-lived assets to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use and eventual disposition of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value less cost to sell or dispose, determined based on discounted cash flows. During the years ended December 31, 2025 and 2024, we recorded $1,881,082 and $-0-, respectively, impairment loss in those periods. The decision to write-down the mining concessions acquired on September 12, 2025 was driven by the lack of reliability of and availability of independent valuations for these unique assets, as necessary to substantiate their value on these financial statements. Baltum presently owns 6,377 hectares of exploitation-level mining concessions in the San Juan mining district, which were recorded as fully impaired and written down to $-0- value from approximately $10.7 million on the Company’s facilities located in the San Juan mining district of Chile. Under a funding level that allows the Company to focus on exploration, Baltum will continue its exploration activities under these mining concessions toward proving the existence of cobalt and/or copper. Depending on the outcome of the exploration activities, the Company would then consider seeking a preliminary economic assessment, preliminary feasibility study, or definitive feasibility study to validate the expected profitability of constructing a plant to extract the target minerals and process them into saleable products.

1881082

10700000

Environmental Obligations We provide for environmental-related obligations when they are probable and amounts can be reasonably estimated. Where the available information is sufficient to estimate the amount of liability, that estimate has been used. Included in environmental liabilities are costs for the operation, maintenance and monitoring of site remediation plans (“OM&M”). If applicable, such reserves are based on our best estimates for these OM&M plans. Over time we could incur OM&M costs in excess of these reserves. However, we are unable to reasonably estimate an amount in excess of any recorded reserves because we cannot reasonably estimate the period for which such OM&M plans will need to be in place or the future annual cost of such remediation, as conditions at environmental sites change over time. If applicable, such additional OM&M costs could be significant in total but would be incurred over an extended period of years. Environmental remediation charges represent the costs for continuing charges associated with environmental remediation at operating sites from previous years and from products that are no longer manufactured and are currently not applicable.

Leases The Company determines if an arrangement is a lease at the inception of the contract. If applicable, our operating leases are included in Operating lease right-of-use (“ROU”) assets, operating lease liabilities – current, and Operating lease liabilities – long term in the consolidated balance sheets. The operating lease ROU assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit interest rate, we utilize an estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. In determining the discount rate used in the present value calculation, the Company has elected to apply the portfolio approach for leases provided the leases commenced at or around the same time. This election allows the Company to account for leases at a portfolio level provided that the resulting accounting at this level would not differ materially from the accounting at the individual lease level. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. If leases are applicable, the Company has elected not to separate lease and non-lease components and accounts for each separate lease component and non-lease component associated with that lease component as a single lease component. Operating lease ROU assets include all contractual lease payments and initial direct costs incurred less any lease incentives. Facility leases generally only contain lease expense and non-component items such as taxes and pass-through charges. Additionally, we have elected not to apply the recognition requirements of ASC 842 to leases which have a lease term of less than one year at the commencement date.

Mining Concessions Mining concessions are recorded at cost based on the payments required under the contracts. Amortization begins when placed in service after the mining concession is exercised. Mining concessions are amortized over their useful life based on the pattern over which the mining concessions are consumed or otherwise used up. Determination of expected useful lives for amortization calculations is made on a property-by-property or asset-by-asset basis at least annually. At the time an ore body can be economically developed, the basis of the mining concession will be amortized on a units-of-production basis. Pursuant to our policy on the impairment of long-lived assets, if it is determined that a mining concession cannot be economically developed or its innate value has not been independently substantiated, the basis of the mining concession is reduced to its fair value and an impairment loss is recorded to expense in the period in which it is determined to be impaired. Finite-lived intangible assets are tested for impairment when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. Intangible assets that are not subject to amortization are tested for impairment annually and more frequently if events or changes in circumstances indicate that is more likely than not, meaning more than 50%, that the asset is impaired. The value of the exploitation mining concessions owned by Baltum has yet to be independently substantiated by a valuation or any level of feasibility study. As of December 31, 2025, and December 31, 2024, these mining concessions had a value of $-0- and $-0-, respectively on the Company’s consolidated balance sheet. 0 0 Restructuring and Other Charges We continually perform strategic reviews and assess the returns on our businesses. In the event that this results in a plan to restructure the operations of our business, we record an accrual for severance and other exit costs under the provisions of the relevant accounting guidance.

Research and Development Research and development costs are expensed as incurred.

Foreign Currency The reporting currency of the Company is the U.S. dollar. The functional currency of Baltum, the Company’s wholly-owned subsidiary, is the Chilean Peso. The assets and liabilities of Baltum are translated into U.S. dollars based on exchange rates at the end of each reporting period. Expenses are translated at average exchange rates during the reporting period. Gains and losses arising from the translation of assets and liabilities are included as a component of accumulated other comprehensive income or loss within the Company’s consolidated balance sheet. Gains and losses resulting from foreign currency transactions are reflected within the Company’s consolidated statements of operations. Transactions denominated in foreign currency other than our functional currency of the foreign operation are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are remeasured at each reporting date into the functional currency at the exchange rate at that date. The Company has not utilized foreign currency hedging strategies to mitigate the effect of its foreign currency exposure. We recorded transaction and remeasurement gains of $-0.0- million and $-0.0- million for the years ended December 31, 2024 and 2025, respectively.

Income Taxes The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company’s tax returns. Deferred taxes are determined based on the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. The potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. The Company’s wholly owned subsidiary is subject to foreign corporate tax in foreign taxing jurisdictions. We do not provide income taxes on the equity in undistributed earnings of consolidated foreign subsidiaries as it is our intention that such earnings will remain invested in those companies. The Company accounts for income taxes in accordance with ASC 740, “Accounting for Income Taxes” (“ASC 740”). Under ASC 740, income tax expense includes federal and state taxes currently payable and deferred taxes arising from temporary differences between income for financial reporting and income tax purposes. In accordance with ASC 740, the Company has evaluated its tax positions. A tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that has a likelihood of being realized on examination of more than 50 percent. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. Under the “more likely than not” threshold guidelines, the Company believes no significant uncertain tax positions exist, either individually or in the aggregate, that would give rise to the non-recognition of an existing tax benefit. The Company’s policy is to account for interest expense and penalties related to unrecognized tax benefits as a component of income tax expense. The Company is currently not under examination with any federal, state, or foreign taxing authorities. In addition, the Company had no material unrecognized tax benefits or accrued interest and penalties as of and for the year ended December 31, 2025.

Concentration of Credit Risk and of Significant Vendors The Company maintains cash balances at financial institutions in the U.S. and Chile. The Company holds all cash balances at accredited financial institutions, in amounts that exceed federally insured limits in the United States of America. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.

Segment Reporting The Company has not yet begun generating revenues from its planned principal operations and operates as a single reportable segment for its mining projects in Chile. The chief operating decision maker is the Company’s chief executive officer, who assesses the performance based on total expenses, cash flows and progress made in the Company’s ongoing development efforts. All of the Company’s long-lived assets are located in Chile.

Recently Issued and Adopted Accounting Pronouncements The Company’s management has evaluated all the recently issued accounting pronouncements through the filing date of these financial statements, including ASC 2023-09, and does not believe that any of these pronouncements will have a material impact on the Company’s current financial position and results of operations.

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">4.</td> <td>Property and Equipment, Net</td></tr> </table> Property and equipment, net consisted of the following: <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zTnmXUrn21i2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, Net (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of property and equipment, net</td><td> </td> <td colspan="2" id="xdx_491_20251231_zC9Mzdp9XFeb" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20241231_zitMQoU7MzFg" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--MachineryAndEquipmentGross_iI_pp0p0_maPPAEGzeTX_znKBLUvmlF95" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Machinery and equipment</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">29,583</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">29,583</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iTI_pp0p0_mtPPAEGzeTX_maPPAENzj8w_zHMzKqoByEd2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Property and equipment, gross</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,583</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,583</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzj8w_z60UQlOL6RMa" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(26,625</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(26,625</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzj8w_znT7LaFhWtj3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,958</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,958</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Depreciation expenses for the years ended December 31, 2025, and December 31, 2024, amounted to $-0- and $-0-, respectively. Loss on retirement of assets for the years ended December 31, 2025, and December 31, 2024, amounted to $-0- and $-0-, respectively.

<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zTnmXUrn21i2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, Net (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of property and equipment, net</td><td> </td> <td colspan="2" id="xdx_491_20251231_zC9Mzdp9XFeb" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20241231_zitMQoU7MzFg" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--MachineryAndEquipmentGross_iI_pp0p0_maPPAEGzeTX_znKBLUvmlF95" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Machinery and equipment</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">29,583</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">29,583</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentGross_iTI_pp0p0_mtPPAEGzeTX_maPPAENzj8w_zHMzKqoByEd2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Property and equipment, gross</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,583</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,583</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzj8w_z60UQlOL6RMa" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(26,625</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(26,625</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzj8w_znT7LaFhWtj3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,958</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,958</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

29583

26625

2958

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">5.</td> <td>Accrued Expenses</td></tr> </table> Accrued expenses consisted of the following: <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zMUOQvT2HzHb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of accrued expenses</td><td> </td> <td colspan="2" id="xdx_493_20251231_zCMGDNicu061" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_496_20241231_zZ10iuQJ8lua" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzY8z_zdeYlW9sAAc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Service fees</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">12,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">14,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedEmployeeBenefitsCurrent_iI_maALCzY8z_zrTXDWhvqBz9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Employee benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzY8z_zrFyoLmiEwqh" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">444</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">441</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzY8z_zZyb9apL11t4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total accrued expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,044</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,441</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zMUOQvT2HzHb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of accrued expenses</td><td> </td> <td colspan="2" id="xdx_493_20251231_zCMGDNicu061" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_496_20241231_zZ10iuQJ8lua" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrent_iI_maALCzY8z_zdeYlW9sAAc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Service fees</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">12,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">14,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedEmployeeBenefitsCurrent_iI_maALCzY8z_zrTXDWhvqBz9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Employee benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzY8z_zrFyoLmiEwqh" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">444</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">441</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzY8z_zZyb9apL11t4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total accrued expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,044</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,441</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

12500

14000

2100

2000

444

441

15044

16441

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">6.</td> <td>Stockholders’ Equity</td></tr> </table> Preferred Stock The Company’s certificate of incorporation authorized the Company to issue 25,000,000 shares of Preferred Stock, $0.0001 par value. On December 28, 2017, a Certificate of Designations was approved by the Board of Directors that authorized the issuance of 7,500,000 shares of Series A Convertible Preferred Stock, of which 5,151,125 were issued and then later converted to common stock on August 10, 2020. Once converted the provisions of the Certificate of Designations do not allow for the re-issuance of those shares. On December 26, 2024, a Certificate of Designations was approved by the Board of Directors that authorized the issuance of 2,600,000 shares of Series B Convertible Preferred Stock. Then on December 29, 2024, an amended and restated Certificate of Designations was approved by the Board of Directors that authorized the issuance of 2,900,000 shares of Series B Convertible Preferred Stock (an increase of 300,000 shares), among other terms and conditions. The Certificate of Designations allows for anti-dilution protection and includes a provision that all Preferred shares were to convert to their common stock equivalent, at a ratio of one share of preferred equals one share of common stock, subject to adjustments for dividends, splits and/or anti-dilution, as of December 31, 2025. All <span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--SeriesBConvertiblePreferredIntoCommonStockMember_z4554Bg7cpa" title="Stock converted, shares converted">2,407,785 shares of Series B Convertible Preferred Stock converted to common stock on December 31, 2025. There were <span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zv5K9v5yVOtd" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zJVWysbEOKM9" title="Preferred stock, shares outstanding">no shares of Series A Convertible Preferred Stock and -0- and 724,420 shares of Series B Convertible Preferred Stock issued and outstanding as of December 31, 2025, and/or December 31, 2024, respectively. 2025 Issuances: During the year ended December 31, 2025, the Company issued the following shares of preferred stock: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify"><span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z89YA2GQJkka" title="Stock issued new, shares">1,683,365 shares of Series B Convertible Preferred Stock were issued to investors at $0.45 per share for total proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--CashReceivedMember_zwn3BNbH2g69" title="Proceeds from issuance of Convertible Preferred stock">757,514.25. In addition, $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--SubscriptionsReceivableMember_z0xY1mWhMG76" title="Proceeds from issuance of Convertible Preferred stock">73,431 of Subscriptions Receivable were received in cash for an overall total of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zir4baHd6Xb7" title="Proceeds from issuance of Convertible Preferred stock">830,945.25 cash received in the twelve-month period.</td></tr> </table> 2024 Issuances: During the year ended December 31, 2024, the Company issued the following shares of preferred stock: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify"><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zYwTTQXKzEKd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">724,420 shares of Series B Convertible Preferred Stock were issued to investors at $0.45 per share for total commitments of $325,989. Of the $325,989 in commitments, $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--CashReceivedMember_zDD4v9DppSSd">252,558 was received in cash by December 31, 2024 and $7<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--SubscriptionsReceivableMember_zC8zowhRtXu9">3,431 was reflected as Subscriptions Receivable at December 31, 2024 and all amounts due were received in cash by shortly after year-end.</td></tr> </table> Common Stock The Company’s certificate of incorporation authorizes the Company to issue 100,000,000 shares of $0.0001 par value common stock. As of December 31, 2025, and December 31, 2024, there were 56,409,930 and 43,502,145 shares of common stock issued and outstanding, respectively. Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders. 2025 Issuances: During the year ended December 31, 2025, the Company issued the following shares of common stock: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify"><span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pn5n6_c20250101__20251231__srt--CounterpartyNameAxis__custom--CobaltChileSpaMember_zlGHgzU95akg" title="Stock issued for aquisition, shares">4.5 million shares were issued to Cobalt Chile SpA on September 12, 2025, on behalf of Baltum, for it to acquire 30 full-exploitation mining concessions at the fair value price on the date of issuance of $0.42 per share, which equates to total acquisition value of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20250101__20251231__srt--CounterpartyNameAxis__custom--CobaltChileSpaMember_z9B3OKMfyvAd" title="Stock issued for acquisition, value">1,890,000, as reflected in the supplemental disclosure of non-cash financing activities in the financial statements.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify">6 million shares overall were issued to Madesal SpA (4 million shares) and Glencore Ltd (2 million shares) on December 2, 2025, at the fair value price on the date of issuance of $0.50 per share for total gross proceeds of $3,000,000, and after reducing for $247,500 of direct and incremental costs of the raise, there were net proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250101__20251231__srt--CounterpartyNameAxis__custom--MadesalSpAAndGlenoreMember_zE8R3gCSukJf" title="Proceeds from issuance of common stock">2,752,500.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify"><span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--SeriesBConvertiblePreferredIntoCommonStockMember_zngB80oMtAsi" title="Stock converted, shares converted">2,407,785 shares were converted at one share of common issued for every one share of Series B Convertible Preferred tendered on December 31, 2025, as indicated previously in the Preferred Stock section.</td></tr> </table> 2024 Issuances: During the year ended December 31, 2024, the Company issued the following shares of common stock: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">·</td> <td style="text-align: justify">216,429 shares were issued to a vendor on March 19, 2024, for a year of services at the fair value price on the date of issuance of $0.26 per share, which equates to total annual compensation paid in the amount of $56,272. Since the stock had not traded as of the date of issuance, the $0.26 per share was used as it was the offering price for the most recently completed private placement capital raise by the Company on April 12, 2023. The stock-based compensation was amortized quarterly for the year of service. As of December 31, 2024, all $56,272 of the stock-based compensation is reflected in the financial statements as non-cash expense.</td></tr> </table> Stock Options and Restricted Stock Units On April 26, 2022, the board adopted, and by shareholder consent achieved on April 29, 2022, the shareholders approved the Company’s 2022 Equity Incentive Plan (the “2022 Plan”), which allows awards for up to 5,850,000 options to purchase <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20220426__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zHCo42UQeuJd" title="Shares authorized for issuance under plan">5,850,000 shares of its Common Stock at prevailing fair value exercise prices at the time of each award. There were <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20251231__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2022Member_zzqdJhTpFaNj" title="Options available for grant">5,611,254 options to purchase 5,611,254 shares of its Common Stock, net of forfeitures, awarded under the 2022 Plan as of December 31, 2025. The purposes of the 2022 Plan are (i) to attract and retain the best available personnel for positions of substantial responsibility, (ii) to provide additional incentives to Employees, Directors, and Consultants, and (iii) to promote the success of the Company’s business. On May 24, 2022, the Company granted stock options to purchase an aggregate of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220523__20220524__srt--TitleOfIndividualAxis__custom--OfficersManagersAdvisorsAndDirectorsMember_zxf2nZiUunM5" title="Options granted, shares">5,025,000 shares to officers/management, advisors, and directors at an exercise price of $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220523__20220524__srt--TitleOfIndividualAxis__custom--OfficersManagersAdvisorsAndDirectorsMember_pdd" title="Options granted, exercise price">0.20. <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20220523__20220524__srt--TitleOfIndividualAxis__custom--OfficersManagersAdvisorsAndDirectorsMember" title="Option terms of award">The options vest quarterly starting on June 30, 2022, for 25% of the granted shares and then the remainder in equal installments over a one-and-one-half-year period and expire in 10 years from the date of the grant. On June 1, 2022, the Company granted stock options to purchase an aggregate of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220530__20220601__srt--TitleOfIndividualAxis__custom--AnAdvisorMember_zRdrNWVvbMj2" title="Options granted, shares">80,004 shares to an advisor at an exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220530__20220601__srt--TitleOfIndividualAxis__custom--AnAdvisorMember_pdd" title="Options granted, exercise price">0.20. The options vest quarterly in equal installments over a one-year period and expire in 10 years from the date of grant. On July 15, 2022, the Company granted stock options to purchase an aggregate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220714__20220715__srt--TitleOfIndividualAxis__custom--AnOfficerMember_ziEErbD34CDd" title="Options granted, shares">450,000 shares to an officer at an exercise price of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220714__20220715__srt--TitleOfIndividualAxis__custom--AnOfficerMember_pdd" title="Options granted, exercise price">0.20. The options vest quarterly starting on September 30, 2022, for 25% of the granted shares and then the remainder in equal installments over a three-quarter year period and expire in 10 years from the date of grant. On July 28, 2022, the Company granted stock options to purchase an aggregate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220727__20220728__srt--TitleOfIndividualAxis__custom--OfficerAndDirectorMember_zQACkck0BdAd" title="Options granted, shares">150,000 shares to an officer/director at an exercise price of $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220727__20220728__srt--TitleOfIndividualAxis__custom--OfficerAndDirectorMember_z1TelMBLtK9f" title="Options granted, exercise price">0.20. <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20220727__20220728__srt--TitleOfIndividualAxis__custom--OfficerAndDirectorMember_zO7lbhc2yP4j" title="Option terms of award">The options vest quarterly starting on September 30, 2022, for 12.5 % of the granted shares and then the remainder in equal installments over a one-and-three-quarter-year period and expire in 10 years from the date of grant. On June 29, 2023, the board adopted, and by shareholder consent achieved on June 30, 2023, the shareholders approved the Company’s 2023 Equity Incentive Plan (the “2023 Plan”), which allows awards for up to 1,963,746 options to purchase 1,963,746 shares of its Common Stock at prevailing fair value exercise prices at the time of each award. There were 1,870,000 options to purchase 1,870,000 shares of its Common Stock awarded under the 2023 Plan as of December 31, 2025. The purposes of the 2023 Plan are (i) to attract and retain the best available personnel for positions of substantial responsibility, (ii) to provide additional incentives to Employees, Directors, and Consultants, and (iii) to promote the success of the Company’s business. On July 1, 2023, the Company granted stock options to purchase an aggregate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230628__20230701__srt--CounterpartyNameAxis__custom--OfficersManagementAndDirectorsMember_zW2AUCz2BIjh" title="Options granted, shares">750,000 shares to officers/management and directors at an exercise price of $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230628__20230701__srt--CounterpartyNameAxis__custom--OfficersManagementAndDirectorsMember_zoyISJkVC3N8" title="Options granted, exercise price">0.26. <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20230628__20230701__srt--CounterpartyNameAxis__custom--OfficersManagementAndDirectorsMember_zJ98c0evQWGi" title="Option terms of award">The options vest quarterly starting on October 1, 2023, in equal installments over a two-year period and expire in 10 years from the date of grant. On July 7, 2023, the Company granted stock options to purchase an aggregate of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230706__20230707__srt--CounterpartyNameAxis__custom--DirectorsMember_zs98Lu5Eq6g5" title="Options granted, shares">300,000 shares to directors at an exercise price of $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230706__20230707__srt--CounterpartyNameAxis__custom--DirectorsMember_pdd" title="Options granted, exercise price">0.26. The options vest quarterly starting on October 1, 2023, for 12.5% of the granted shares and then the remainder in equal installments over a one-and-one-half-year period and expire in 10 years from the date of grant. On January 25, 2024, the Company granted stock options to purchase an aggregate of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240124__20240125__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zM1KS9StIVR5" title="Options granted, shares">75,000 shares to advisory board members at an exercise price of $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240124__20240125__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_pdd" title="Options granted, exercise price">0.26. The options vest quarterly starting on March 31, 2024, for 25% of the granted shares and then the remainder in equal installments at each quarter-end through the end of 2024 and expire in 10 years from the date of grant. On February 13, 2024, the Company granted stock options to purchase an aggregate of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240212__20240213__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zbZwG7BFrORi" title="Options granted, shares">50,000 shares to an advisory board member at an exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240212__20240213__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_pdd" title="Options granted, exercise price">0.26. The options vest quarterly starting on March 31, 2024, for 25% of the granted shares and then the remainder in equal installments at each quarter-end through the end of 2024 and expire in 10 years from the date of grant. On January 17, 2025, the Company granted stock options to purchase an aggregate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250116__20250117__srt--TitleOfIndividualAxis__custom--OfficersDirectorsAndAdvisoryBoardMember_zanMdk1Kdlkg" title="Options granted, shares">645,000 shares to officers/management, directors, contractors and advisory board members at an exercise price of $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20250116__20250117__srt--TitleOfIndividualAxis__custom--OfficersDirectorsAndAdvisoryBoardMember_zE7rufvFoPz5" title="Options granted, exercise price">0.50. The <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250116__20250117__srt--TitleOfIndividualAxis__custom--OfficersDirectorsAndAdvisoryBoardMember__us-gaap--VestingAxis__custom--Vesting125GrantedSharesMember_zUREZjnQelV" title="Options granted, shares">570,000 options awarded to officers/management, directors and contractors vest quarterly starting on March 31, 2025, for 12.5% of the granted shares and then the remainder in equal installments at each quarter-end through the end of 2026 and expire <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20250101__20251231__srt--TitleOfIndividualAxis__custom--OfficersDirectorsAndContractorsMember_zEM5OslhvP52" title="Expiration years">10 years from the date of grant. The <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250116__20250117__srt--TitleOfIndividualAxis__custom--OfficersDirectorsAndAdvisoryBoardMember__us-gaap--VestingAxis__custom--Vesting25GrantedSharesMember_z8FoZ7UT2xd4" title="Options granted, shares">75,000 options awarded to advisory board members vest quarterly starting on March 31, 2025, for 25% of the granted shares and then the remainder in equal installments at each quarter-end through the end of 2025 and expire in <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20250101__20251231__srt--TitleOfIndividualAxis__custom--AdvisoryBoardMember_zbJ4bT2GIJEa" title="Expiration years">10 years from the date of grant. On July 29, 2025, the Company granted stock options to purchase an aggregate of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250728__20250729__srt--TitleOfIndividualAxis__srt--DirectorMember_zaf3AOKiCu7i" title="Options granted, shares">50,000 shares to a director at an exercise price of $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20250728__20250729__srt--TitleOfIndividualAxis__srt--DirectorMember_zdB2PA6m6hJl" title="Options granted, exercise price">0.37. <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20250728__20250729__srt--TitleOfIndividualAxis__srt--DirectorMember_zxjg0Rb2kkBf" title="Option terms of award">The 50,000 options awarded to the director vested in full immediately upon award and expire in 10 years from the date of grant. On July 24, 2025, the board approved, and by shareholder consent achieved on August 27, 2025, the shareholders adopted the Company’s 2025 Equity Incentive Plan (the “2025 Plan”), which allows awards for up to 5,000,000 shares of its common stock to be awarded in various equity incentive formats at prevailing fair value exercise prices at the time of each award. There were <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250725__20251231__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2025Member__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyAXpFSw9mfb">500,000 Restricted Stock Units (RSUs) related to its Common Stock awarded under the 2025 Plan as of December 31, 2025. The purposes of the 2025 Plan are (i) to attract and retain the best available personnel for positions of substantial responsibility, (ii) to provide additional incentives to Employees, Directors, and Consultants, and (iii) to promote the success of the Company’s business. On August 28, 2025, the Company granted <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250827__20250828__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2025Member__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--ADirectorMember_zVgeiHUWtU39">500,000 RSUs related to its Common Stock to a director. The RSUs all vest on July 27, 2027, assuming the Plan Administrator has not accelerated the vesting for any reason and the director is still actively delivering services under the Consulting and Advisory Agreement between director and Company. Stock Options: The fair value of the options granted was estimated on the date of grant using the Black-Scholes options pricing model, with the following weighted average assumptions: <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zx5ncGmgTX38" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions used for valuating options</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of December 31, 2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Expected dividend yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">0.00%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">0.00%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected stock volatility (a)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">67.20%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">129.10%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.027%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.625%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected life of options (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zP2gH5ch4tPj" title="Expected life of options (years)">3.00 - <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zbdhBYAkEgFl" title="Expected life of options (years)">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zowlDH6415h7" title="Expected life of options (years)">3.00 - <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_zwTAMKUP2NLk" title="Expected life of options (years)">5.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Expected forfeiture rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Grant date fair value range per option issued</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zeOmSfb5fSmj" title="Grant date fair value per option">0.1251 - <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zqGbeMWNtxzk" title="Grant date fair value per option">0.1251</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zf9N6DPHDLj9" title="Grant date fair value per option">0.3197 - <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_zDDYjogk98Z2" title="Grant date fair value per option">0.4020</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in">(a)</td> <td style="text-align: justify">At the time of determination of expected stock volatility, the Company’s securities were trading over-the-counter as an OTCQB traded stock, but for less than two years and under limited trading volume such that calculated volatility based solely on the Company’s volatility isn’t necessarily indicative of the expected volatility over the expected life of the options and RSUs. Therefore, the expected stock volatility was estimated using three public companies in the same industry as the Company and calculating an equal-weighted and blended volatility of the Company’s volatility and the volatility of those three believed-to-be-representative companies over the same period.</td></tr> </table> During the years ended December 31, 2025, and December 31, 2024, the Company recorded stock-based compensation expenses of $188,398 and $101,728, respectively. As of December 31, 2025, the unamortized stock option expense was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pp0p0_c20251231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_z9LxPvHIj5Gj" title="Unamortized stock option expense">98,416. The Company’s stock options had an intrinsic value of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_pp0p0_c20251231__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zMFwPr66bay7" title="Stock options intrinsic value">16,524,884, based on the OTCQB published closing price for (OTCQB: COBA) of $2.46 per share as of December 31, 2025, which may not be indicative of the true market value of the stock options given the limited historical volumes traded and the volatility of the underlying shares as of that date. Stock-based compensation expense is measured at the date of grant, based on the fair value of the award, and is recognized over the vesting period of the option. The Company recognizes forfeitures in stock-based compensation expense as they occur. A summary of the changes in stock options outstanding at December 31, 2025, are presented below: <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zzl5fKtAQima" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Option activity)"> <tr style="vertical-align: bottom"> <td>Schedule of changes in stock options outstanding</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Options Outstanding Number of Shares</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Balance, December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231_zs0lqilQ7nlb" title="Options outstanding number of shares, Beginning balance">6,661,254</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zPGRAQisjv92" title="Weighted average exercise price, Beginning balance">0.21</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231_z5okwmXo36C2" title="Weighted average exercise price, Options issued">0.26</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Expired/Forfeited</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">n/a</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">n/a</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Balance, December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20250101__20251231_z4LafdswVbdl" title="Options outstanding number of shares, Beginning balance">6,786,254</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20250101__20251231_z9X0m2Qrt82c" title="Weighted average exercise price, Beginning balance">0.21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">695,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20250101__20251231_zj1MfGz8VFie" title="Weighted average exercise price, Options issued">0.49</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Expired/Forfeited</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20250101__20251231_zu8wD8dyslae" title="Weighted average exercise price, Expired/Forfeited">0.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">n/a</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance, December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,425,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20250101__20251231_zxlGWs8Votna" title="Weighted average exercise price, Ending balance">0.23</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company has the following options outstanding and exercisable at December 31, 2025 and December 31, 2024: <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z1l9fWnKRATe" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders' Equity (Details - Options by price)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of options outstanding and exercisable</td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td colspan="11" style="border-bottom: black 1pt solid; text-align: center">December 31, 2025</td> <td> </td> <td colspan="11" style="border-bottom: black 1pt solid; text-align: center">December 31, 2024</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: left">Issue Date</td> <td> </td> <td style="border-bottom: black 1pt solid">Expiry Date</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Exercise Price</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Stock Options Outstanding</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Stock Options Exercisable</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Remaining Life</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Exercise Price</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Stock Options Outstanding</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Stock Options Exercisable</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Remaining Life</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; width: 19%"><span id="xdx_903_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zk2v8rwZj6Xj" title="Option issue date">May 24, 2022</td> <td style="width: 1%"> </td> <td style="width: 11%"><span id="xdx_908_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zi5Rp01QeVz4" title="Option expiration date">May 24, 2032</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zufg3c3Kmiwb" style="width: 6%; text-align: right" title="Option exercise price">0.20</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zq6YGMoFd1h" style="width: 7%; text-align: right" title="Options outstanding">4,931,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zBehClLitIRc" style="width: 7%; text-align: right" title="Options exercisable">4,931,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 6%; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zLf1teT5WY4c" title="Remaining life">6.40</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zTXbpYmHtiD3" style="width: 6%; text-align: right" title="Option exercise price">0.20</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zHOBi4oN34hi" style="width: 7%; text-align: right" title="Options outstanding">4,931,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_z74V1tAjhV73" style="width: 7%; text-align: right" title="Options exercisable">4,931,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 6%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_ze4uZWyIAEq6" title="Remaining life">7.40</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90D_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zS6e8uzNxEP3" title="Option issue date">June 1, 2022</td> <td> </td> <td><span id="xdx_901_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zD7dgQHOiL5d" title="Option expiration date">June 1, 2032</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zUp9A1tu3Ich" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zXfDbMacXB84" style="text-align: right" title="Options outstanding">80,004</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zXz9cNsPnC05" style="text-align: right" title="Options exercisable">80,004</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zu1ing4xh8Ja" title="Remaining life">6.42</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zEfMtG04mWv2" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zYk71qE882h" style="text-align: right" title="Options outstanding">80,004</td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zwSLwYlpwaC6" style="text-align: right" title="Options exercisable">80,004</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zkXFswpAQTUa" title="Remaining life">7.42</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span id="xdx_906_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zePtj6tGOKZh" title="Option issue date">July 15, 2022</td> <td> </td> <td><span id="xdx_908_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zwlxvpW8MtV7" title="Option expiration date">July 15, 2032</td> <td> </td> <td>$</td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zcpp2T0mDRF1" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zKl9IUe2H7Nb" style="text-align: right" title="Options outstanding">450,000</td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zMoaLCw21vck" style="text-align: right" title="Options exercisable">450,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_z6FNLtcimdAd" title="Remaining life">6.55</td> <td> </td> <td>$</td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zygodcci1rQg" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_z5b7xTLpZpo6" style="text-align: right" title="Options outstanding">450,000</td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_z7KGZE12HDKa" style="text-align: right" title="Options exercisable">450,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zHYOe1ZF0uK" title="Remaining life">7.54</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90E_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z75LshTGfNe8" title="Option issue date">July 28, 2022</td> <td> </td> <td><span id="xdx_90A_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zJm5PHE7Frm7" title="Option expiration date">July 28, 2032</td> <td> </td> <td>$</td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zxQLUVBaKf5" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z5F2673doGk9" style="text-align: right" title="Options outstanding">150,000</td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z23Rh9T6VDM5" style="text-align: right" title="Options exercisable">150,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z6a15NW9umQe" title="Remaining life">6.58</td> <td> </td> <td>$</td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zmqrEA8zZuPh" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zmglFW8fMkUj" style="text-align: right" title="Options outstanding">150,000</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z4sH613zCtR5" style="text-align: right" title="Options exercisable">150,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zTqBaPYNnX4c" title="Remaining life">7.58</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span id="xdx_902_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_ziZNTUagTdSg" title="Option issue date">July 1, 2023</td> <td> </td> <td><span id="xdx_90B_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zotY9ROBRf49" title="Option expiration date">July 1, 2033</td> <td> </td> <td>$</td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zJqiWUrSzuh6" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_z73eObC1qiCi" style="text-align: right" title="Options outstanding">750,000</td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zrQnvdMNbxb4" style="text-align: right" title="Options exercisable">750,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zMrHfqArbEb8" title="Remaining life">7.51</td> <td> </td> <td>$</td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_z3MK90IZvBt5" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zYGev3Z7HiH2" style="text-align: right" title="Options outstanding">750,000</td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zpD5r5vTk3H2" style="text-align: right" title="Options exercisable">496,875</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zsUv64GyjtW2" title="Remaining life">8.50</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_903_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zIgZfxpHTGH6" title="Option issue date">July 7, 2023</td> <td> </td> <td><span id="xdx_903_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zeNr27QXLebk" title="Option expiration date">July 7, 2033</td> <td> </td> <td>$</td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_z5wSsSDGOKI" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zSZr2nqTBq0g" style="text-align: right" title="Options outstanding">300,000</td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_z6N0X6Emxxq5" style="text-align: right" title="Options exercisable">300,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zttUAWPh1dDa" title="Remaining life">7.52</td> <td> </td> <td>$</td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zgecE55rTmoh" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zR6W0rwqYzM5" style="text-align: right" title="Options outstanding">300,000</td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zPZ7BCsU3v8d" style="text-align: right" title="Options exercisable">187,500</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zzsHvJTmmM91" title="Remaining life">8.52</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span id="xdx_905_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_z1XVxGwYwblf" title="Option issue date">January 25, 2024</td> <td> </td> <td><span id="xdx_904_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zMK5x5DlBDOe" title="Option expiration date">January 25, 2034</td> <td> </td> <td>$</td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zkSCOqCtk51g" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_z7HoVBzqcUGf" style="text-align: right" title="Options outstanding">75,000</td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zkEZCeAFH1Pe" style="text-align: right" title="Options exercisable">75,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zrqadMJR6RLj" title="Remaining life">8.08</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zIhbgjWDpsA1" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zEW3WbUiTC4a" style="text-align: right" title="Options outstanding">75,000</td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zIHwavU1g7Rd" style="text-align: right" title="Options exercisable">75,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zCB4tX3Fkd6c" title="Remaining life">9.07</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90C_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zKW7DXcTyo3h" title="Option issue date">February 13, 2024</td> <td> </td> <td><span id="xdx_90B_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zTHPwcN962Yf" title="Option expiration date">February 13, 2034</td> <td> </td> <td>$</td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zUJcAfHe8Xjd" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zeL4ZsuVExok" style="text-align: right" title="Options outstanding">50,000</td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zL7AjNtvlCvc" style="text-align: right" title="Options exercisable">50,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zsDN3NMB4th2" title="Remaining life">8.13</td> <td> </td> <td>$</td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_z7S6oRVmzv6a" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zTYRSuEUq8j4" style="text-align: right" title="Options outstanding">50,000</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zfilHXSbZak7" style="text-align: right" title="Options exercisable">50,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zCqhtr0okJvh" title="Remaining life">9.13</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span id="xdx_90F_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zFeqHIGIBOe7" title="Option issue date">January 17, 2025</td> <td> </td> <td><span id="xdx_904_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zRK1SPGGaHAh" title="Option expiration date">January 17, 2035</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zRUS7iXZTt6k" style="text-align: right" title="Option exercise price">0.50</td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zhwKswQ173A9" style="text-align: right" title="Options outstanding">588,750</td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zI97MSvExLD8" style="text-align: right" title="Options exercisable">341,250</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zSVkPaOIQJkb" title="Remaining life">9.05</td> <td> </td> <td>$</td> <td style="text-align: right">n/a </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_d0_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_znXV5qVMEx9i" style="text-align: right" title="Options outstanding">–</td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_d0_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zw44eRq6GMWk" style="text-align: right" title="Options exercisable">–</td> <td> </td> <td> </td> <td style="text-align: right">n/a</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_903_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zPTLyoRs8oC4" title="Option issue date">July 29, 2025</td> <td> </td> <td><span id="xdx_90C_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zgZNBRCMmIE8" title="Option expiration date">July 29, 2035</td> <td> </td> <td>$</td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zeelC3xNrim4" style="text-align: right" title="Option exercise price">0.37</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zbAzCUH5x4c1" style="border-bottom: black 1pt solid; text-align: right" title="Options outstanding">50,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zopaFeBS6y8i" style="border-bottom: black 1pt solid; text-align: right" title="Options exercisable">50,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_z0BuNR9yMIs4" title="Remaining life">9.58</td> <td> </td> <td> </td> <td style="text-align: right">n/a </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_d0_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zS9mF8vxuqZ1" style="border-bottom: black 1pt solid; text-align: right" title="Options outstanding">–</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_d0_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zb4X8SxadIk4" style="border-bottom: black 1pt solid; text-align: right" title="Options exercisable">–</td> <td> </td> <td> </td> <td style="text-align: right">n/a</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Totals and Weighted Averages Outstanding</td> <td> </td> <td> </td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231_zhxavrfN5Vn8" style="text-align: right" title="Option exercise price">0.23</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231_zOtld3UrSS8l" style="border-bottom: black 2.25pt double; text-align: right" title="Options outstanding">7,425,004</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231_zvsxIts3NKH3" style="border-bottom: black 2.25pt double; text-align: right" title="Options exercisable">7,177,504</td> <td> </td> <td> </td> <td style="text-align: right">6.83</td> <td> </td> <td>$</td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231_zmU28CFzwcB5" style="text-align: right" title="Option exercise price">0.21</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231_z6rfVU26ixE4" style="border-bottom: black 2.25pt double; text-align: right" title="Options outstanding">6,786,254</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zcSwToS4u8w4" style="border-bottom: black 2.25pt double; text-align: right" title="Options exercisable">6,420,629</td> <td> </td> <td> </td> <td style="text-align: right">7.61</td> <td> </td></tr> </table> The Company’s board typically grants annual equity awards during scheduled meetings, independent of MNPI releases. Awards are not timed to coincide with MNPI, and the Company did not intentionally align MNPI releases to influence compensation during the years ended December 31, 2025, and December 31, 2024. For the award on January 17, 2025, there were two covered periods that were triggered related to a Form 8-K filing on January 16, 2025 and another Form 8-K filing on January 22, 2025, the % change in closing price is presented separately and respectively in the table below for those two filings: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Securities Underlying Options (Shares)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price (per Share)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date Fair Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% Change in Closing Price (1)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 27%; text-align: left">Duncan Blount (PEO)</td><td style="width: 2%"> </td> <td style="width: 17%; text-align: center">January 17, 2025</td><td style="width: 2%"> </td> <td style="width: 11%; text-align: right">200,000</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">0.50</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">80,398</td><td style="width: 2%"> </td> <td style="width: 11%; text-align: right">0%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Duncan Blount (PEO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td style="text-align: right">200,000</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">80,398</td><td> </td> <td style="text-align: right">0%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Jim Van Horn (CFO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td style="text-align: right">60,000</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">24,119</td><td> </td> <td style="text-align: right">0%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Jim Van Horn (CFO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td style="text-align: right">60,000</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">24,119</td><td> </td> <td style="text-align: right">0%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Jeremy McCann (COO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td style="text-align: right">25,000</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,050</td><td> </td> <td style="text-align: right">0%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Jeremy McCann (COO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td style="text-align: right">25,000</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,050</td><td> </td> <td style="text-align: right">0%</td></tr> </table> Restricted Stock Units (RSUs): The fair value of the <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250725__20251231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGYQeXK2T1Bi">500,000 RSUs granted was $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c20250827__20250828__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zL8ykqkySS6j" title="Fair value of stock granted">217,500, based on the closing price of $0.435 per share on the grant date of August 28, 2025. During the years ended December 31, 2025, and December 31, 2024, the Company recorded stock-based compensation expenses of $39,207 and $-0-, respectively. As of December 31, 2025, the unamortized RSU expense was $<span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_pp0p0_c20251231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2i6qiJBrFi3" title="Unamortized RSU expense">178,293. The Company’s RSUs had an intrinsic value of $<span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_pp0p0_c20251231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJkKadfE2e5d" title="RSUs intrinsic value">1,230,000, based on the OTCQB published closing price of $2.46 per share as of December 31, 2025, which may not be indicative of the true market value of the stock options given the limited historical volumes traded and the volatility of the underlying shares as of that date. Stock-based compensation expense is measured at the date of grant, based on the fair value of the award, and is recognized over the vesting period of the option. The Company recognizes forfeitures in stock-based compensation expense as they occur.

25000000

0.0001

2600000

2900000

300000

2407785

724420

1683365

757514

73431

830945

724420

325989

252558

3431

100000000

0.0001

56409930

43502145

4500000

1890000

6000000

247500

2752500

2407785

216429

56272

5850000

5611254

5025000

0.20

The options vest quarterly starting on June 30, 2022, for 25% of the granted shares and then the remainder in equal installments over a one-and-one-half-year period and expire in 10 years from the date of the grant.

80004

0.20

The options vest quarterly in equal installments over a one-year period and expire in 10 years from the date of grant.

450000

0.20

The options vest quarterly starting on September 30, 2022, for 25% of the granted shares and then the remainder in equal installments over a three-quarter year period and expire in 10 years from the date of grant.

150000

0.20

The options vest quarterly starting on September 30, 2022, for 12.5 % of the granted shares and then the remainder in equal installments over a one-and-three-quarter-year period and expire in 10 years from the date of grant.

1963746

1870000

750000

0.26

The options vest quarterly starting on October 1, 2023, in equal installments over a two-year period and expire in 10 years from the date of grant.

300000

0.26

The options vest quarterly starting on October 1, 2023, for 12.5% of the granted shares and then the remainder in equal installments over a one-and-one-half-year period and expire in 10 years from the date of grant.

75000

0.26

The options vest quarterly starting on March 31, 2024, for 25% of the granted shares and then the remainder in equal installments at each quarter-end through the end of 2024 and expire in 10 years from the date of grant.

50000

0.26

645000

0.50

570000

P10Y

75000

P10Y

50000

0.37

The 50,000 options awarded to the director vested in full immediately upon award and expire in 10 years from the date of grant.

5000000

500000

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zx5ncGmgTX38" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td>Schedule of assumptions used for valuating options</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of December 31, 2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Expected dividend yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">0.00%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">0.00%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected stock volatility (a)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">67.20%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">129.10%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.027%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.625%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected life of options (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zP2gH5ch4tPj" title="Expected life of options (years)">3.00 - <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zbdhBYAkEgFl" title="Expected life of options (years)">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zowlDH6415h7" title="Expected life of options (years)">3.00 - <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_zwTAMKUP2NLk" title="Expected life of options (years)">5.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Expected forfeiture rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Grant date fair value range per option issued</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231__srt--RangeAxis__srt--MinimumMember_zeOmSfb5fSmj" title="Grant date fair value per option">0.1251 - <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20241231__srt--RangeAxis__srt--MaximumMember_zqGbeMWNtxzk" title="Grant date fair value per option">0.1251</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zf9N6DPHDLj9" title="Grant date fair value per option">0.3197 - <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_zDDYjogk98Z2" title="Grant date fair value per option">0.4020</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in">(a)</td> <td style="text-align: justify">At the time of determination of expected stock volatility, the Company’s securities were trading over-the-counter as an OTCQB traded stock, but for less than two years and under limited trading volume such that calculated volatility based solely on the Company’s volatility isn’t necessarily indicative of the expected volatility over the expected life of the options and RSUs. Therefore, the expected stock volatility was estimated using three public companies in the same industry as the Company and calculating an equal-weighted and blended volatility of the Company’s volatility and the volatility of those three believed-to-be-representative companies over the same period.</td></tr> </table>

0.0000

0.6720

1.2910

0.05027

0.03625

P3Y

P5Y

P3Y

P5Y

0.0000 0.0000

0.1251

0.3197

0.4020

188398

101728

98416

16524884

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zzl5fKtAQima" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details - Option activity)"> <tr style="vertical-align: bottom"> <td>Schedule of changes in stock options outstanding</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Options Outstanding Number of Shares</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Balance, December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20241231_zs0lqilQ7nlb" title="Options outstanding number of shares, Beginning balance">6,661,254</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20241231_zPGRAQisjv92" title="Weighted average exercise price, Beginning balance">0.21</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231_z5okwmXo36C2" title="Weighted average exercise price, Options issued">0.26</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Expired/Forfeited</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">n/a</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">n/a</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Balance, December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20250101__20251231_z4LafdswVbdl" title="Options outstanding number of shares, Beginning balance">6,786,254</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20250101__20251231_z9X0m2Qrt82c" title="Weighted average exercise price, Beginning balance">0.21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">695,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20250101__20251231_zj1MfGz8VFie" title="Weighted average exercise price, Options issued">0.49</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Expired/Forfeited</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20250101__20251231_zu8wD8dyslae" title="Weighted average exercise price, Expired/Forfeited">0.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">n/a</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance, December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,425,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20250101__20251231_zxlGWs8Votna" title="Weighted average exercise price, Ending balance">0.23</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

6661254

0.21

125000

0.26

-0

6786254

0.21

695000

0.49

56250

0.50

7425004

0.23

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_z1l9fWnKRATe" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stockholders' Equity (Details - Options by price)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of options outstanding and exercisable</td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td colspan="11" style="border-bottom: black 1pt solid; text-align: center">December 31, 2025</td> <td> </td> <td colspan="11" style="border-bottom: black 1pt solid; text-align: center">December 31, 2024</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: left">Issue Date</td> <td> </td> <td style="border-bottom: black 1pt solid">Expiry Date</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Exercise Price</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Stock Options Outstanding</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Stock Options Exercisable</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Remaining Life</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Exercise Price</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Stock Options Outstanding</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Stock Options Exercisable</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Remaining Life</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; width: 19%"><span id="xdx_903_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zk2v8rwZj6Xj" title="Option issue date">May 24, 2022</td> <td style="width: 1%"> </td> <td style="width: 11%"><span id="xdx_908_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zi5Rp01QeVz4" title="Option expiration date">May 24, 2032</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zufg3c3Kmiwb" style="width: 6%; text-align: right" title="Option exercise price">0.20</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zq6YGMoFd1h" style="width: 7%; text-align: right" title="Options outstanding">4,931,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zBehClLitIRc" style="width: 7%; text-align: right" title="Options exercisable">4,931,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 6%; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zLf1teT5WY4c" title="Remaining life">6.40</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zTXbpYmHtiD3" style="width: 6%; text-align: right" title="Option exercise price">0.20</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_zHOBi4oN34hi" style="width: 7%; text-align: right" title="Options outstanding">4,931,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_z74V1tAjhV73" style="width: 7%; text-align: right" title="Options exercisable">4,931,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 6%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedMay242022Member_ze4uZWyIAEq6" title="Remaining life">7.40</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90D_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zS6e8uzNxEP3" title="Option issue date">June 1, 2022</td> <td> </td> <td><span id="xdx_901_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zD7dgQHOiL5d" title="Option expiration date">June 1, 2032</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zUp9A1tu3Ich" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zXfDbMacXB84" style="text-align: right" title="Options outstanding">80,004</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zXz9cNsPnC05" style="text-align: right" title="Options exercisable">80,004</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zu1ing4xh8Ja" title="Remaining life">6.42</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zEfMtG04mWv2" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zYk71qE882h" style="text-align: right" title="Options outstanding">80,004</td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zwSLwYlpwaC6" style="text-align: right" title="Options exercisable">80,004</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJune012022Member_zkXFswpAQTUa" title="Remaining life">7.42</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span id="xdx_906_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zePtj6tGOKZh" title="Option issue date">July 15, 2022</td> <td> </td> <td><span id="xdx_908_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zwlxvpW8MtV7" title="Option expiration date">July 15, 2032</td> <td> </td> <td>$</td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zcpp2T0mDRF1" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zKl9IUe2H7Nb" style="text-align: right" title="Options outstanding">450,000</td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zMoaLCw21vck" style="text-align: right" title="Options exercisable">450,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_z6FNLtcimdAd" title="Remaining life">6.55</td> <td> </td> <td>$</td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zygodcci1rQg" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_z5b7xTLpZpo6" style="text-align: right" title="Options outstanding">450,000</td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_z7KGZE12HDKa" style="text-align: right" title="Options exercisable">450,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly152022Member_zHYOe1ZF0uK" title="Remaining life">7.54</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90E_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z75LshTGfNe8" title="Option issue date">July 28, 2022</td> <td> </td> <td><span id="xdx_90A_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zJm5PHE7Frm7" title="Option expiration date">July 28, 2032</td> <td> </td> <td>$</td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zxQLUVBaKf5" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z5F2673doGk9" style="text-align: right" title="Options outstanding">150,000</td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z23Rh9T6VDM5" style="text-align: right" title="Options exercisable">150,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z6a15NW9umQe" title="Remaining life">6.58</td> <td> </td> <td>$</td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zmqrEA8zZuPh" style="text-align: right" title="Option exercise price">0.20</td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zmglFW8fMkUj" style="text-align: right" title="Options outstanding">150,000</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_z4sH613zCtR5" style="text-align: right" title="Options exercisable">150,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly282022Member_zTqBaPYNnX4c" title="Remaining life">7.58</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span id="xdx_902_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_ziZNTUagTdSg" title="Option issue date">July 1, 2023</td> <td> </td> <td><span id="xdx_90B_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zotY9ROBRf49" title="Option expiration date">July 1, 2033</td> <td> </td> <td>$</td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zJqiWUrSzuh6" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_z73eObC1qiCi" style="text-align: right" title="Options outstanding">750,000</td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zrQnvdMNbxb4" style="text-align: right" title="Options exercisable">750,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zMrHfqArbEb8" title="Remaining life">7.51</td> <td> </td> <td>$</td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_z3MK90IZvBt5" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zYGev3Z7HiH2" style="text-align: right" title="Options outstanding">750,000</td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zpD5r5vTk3H2" style="text-align: right" title="Options exercisable">496,875</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly012023Member_zsUv64GyjtW2" title="Remaining life">8.50</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_903_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zIgZfxpHTGH6" title="Option issue date">July 7, 2023</td> <td> </td> <td><span id="xdx_903_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zeNr27QXLebk" title="Option expiration date">July 7, 2033</td> <td> </td> <td>$</td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_z5wSsSDGOKI" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zSZr2nqTBq0g" style="text-align: right" title="Options outstanding">300,000</td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_z6N0X6Emxxq5" style="text-align: right" title="Options exercisable">300,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zttUAWPh1dDa" title="Remaining life">7.52</td> <td> </td> <td>$</td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zgecE55rTmoh" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zR6W0rwqYzM5" style="text-align: right" title="Options outstanding">300,000</td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zPZ7BCsU3v8d" style="text-align: right" title="Options exercisable">187,500</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly072023Member_zzsHvJTmmM91" title="Remaining life">8.52</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span id="xdx_905_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_z1XVxGwYwblf" title="Option issue date">January 25, 2024</td> <td> </td> <td><span id="xdx_904_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zMK5x5DlBDOe" title="Option expiration date">January 25, 2034</td> <td> </td> <td>$</td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zkSCOqCtk51g" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_z7HoVBzqcUGf" style="text-align: right" title="Options outstanding">75,000</td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zkEZCeAFH1Pe" style="text-align: right" title="Options exercisable">75,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zrqadMJR6RLj" title="Remaining life">8.08</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zIhbgjWDpsA1" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zEW3WbUiTC4a" style="text-align: right" title="Options outstanding">75,000</td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zIHwavU1g7Rd" style="text-align: right" title="Options exercisable">75,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan252024Member_zCB4tX3Fkd6c" title="Remaining life">9.07</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_90C_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zKW7DXcTyo3h" title="Option issue date">February 13, 2024</td> <td> </td> <td><span id="xdx_90B_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zTHPwcN962Yf" title="Option expiration date">February 13, 2034</td> <td> </td> <td>$</td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zUJcAfHe8Xjd" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zeL4ZsuVExok" style="text-align: right" title="Options outstanding">50,000</td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zL7AjNtvlCvc" style="text-align: right" title="Options exercisable">50,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zsDN3NMB4th2" title="Remaining life">8.13</td> <td> </td> <td>$</td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_z7S6oRVmzv6a" style="text-align: right" title="Option exercise price">0.26</td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zTYRSuEUq8j4" style="text-align: right" title="Options outstanding">50,000</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zfilHXSbZak7" style="text-align: right" title="Options exercisable">50,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedFeb132024Member_zCqhtr0okJvh" title="Remaining life">9.13</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span id="xdx_90F_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zFeqHIGIBOe7" title="Option issue date">January 17, 2025</td> <td> </td> <td><span id="xdx_904_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zRK1SPGGaHAh" title="Option expiration date">January 17, 2035</td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zRUS7iXZTt6k" style="text-align: right" title="Option exercise price">0.50</td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zhwKswQ173A9" style="text-align: right" title="Options outstanding">588,750</td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zI97MSvExLD8" style="text-align: right" title="Options exercisable">341,250</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zSVkPaOIQJkb" title="Remaining life">9.05</td> <td> </td> <td>$</td> <td style="text-align: right">n/a </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_d0_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_znXV5qVMEx9i" style="text-align: right" title="Options outstanding">–</td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_d0_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJan172025Member_zw44eRq6GMWk" style="text-align: right" title="Options exercisable">–</td> <td> </td> <td> </td> <td style="text-align: right">n/a</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_903_ecustom--OptionIssueDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zPTLyoRs8oC4" title="Option issue date">July 29, 2025</td> <td> </td> <td><span id="xdx_90C_ecustom--OptionExpiryDate_dd_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zgZNBRCMmIE8" title="Option expiration date">July 29, 2035</td> <td> </td> <td>$</td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zeelC3xNrim4" style="text-align: right" title="Option exercise price">0.37</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zbAzCUH5x4c1" style="border-bottom: black 1pt solid; text-align: right" title="Options outstanding">50,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zopaFeBS6y8i" style="border-bottom: black 1pt solid; text-align: right" title="Options exercisable">50,000</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_z0BuNR9yMIs4" title="Remaining life">9.58</td> <td> </td> <td> </td> <td style="text-align: right">n/a </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_d0_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zS9mF8vxuqZ1" style="border-bottom: black 1pt solid; text-align: right" title="Options outstanding">–</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_d0_c20241231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionsIssuedJuly292025Member_zb4X8SxadIk4" style="border-bottom: black 1pt solid; text-align: right" title="Options exercisable">–</td> <td> </td> <td> </td> <td style="text-align: right">n/a</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Totals and Weighted Averages Outstanding</td> <td> </td> <td> </td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231_zhxavrfN5Vn8" style="text-align: right" title="Option exercise price">0.23</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231_zOtld3UrSS8l" style="border-bottom: black 2.25pt double; text-align: right" title="Options outstanding">7,425,004</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20251231_zvsxIts3NKH3" style="border-bottom: black 2.25pt double; text-align: right" title="Options exercisable">7,177,504</td> <td> </td> <td> </td> <td style="text-align: right">6.83</td> <td> </td> <td>$</td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231_zmU28CFzwcB5" style="text-align: right" title="Option exercise price">0.21</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20241231_z6rfVU26ixE4" style="border-bottom: black 2.25pt double; text-align: right" title="Options outstanding">6,786,254</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20241231_zcSwToS4u8w4" style="border-bottom: black 2.25pt double; text-align: right" title="Options exercisable">6,420,629</td> <td> </td> <td> </td> <td style="text-align: right">7.61</td> <td> </td></tr> </table>

2022-05-24 2032-05-24

0.20

4931250

P6Y4M24D

0.20

4931250

P7Y4M24D

2022-06-01 2032-06-01

0.20

80004

P6Y5M1D

0.20

80004

P7Y5M1D

2022-07-15 2032-07-15

0.20

450000

P6Y6M18D

0.20

450000

P7Y6M14D

2022-07-28 2032-07-28

0.20

150000

P6Y6M29D

0.20

150000

P7Y6M29D

2023-07-01 2033-07-01

0.26

750000

P7Y6M3D

0.26

750000

496875

P8Y6M

2023-07-07 2033-07-07

0.26

300000

P7Y6M7D

0.26

300000

187500

P8Y6M7D

2024-01-25 2034-01-25

0.26

75000

P8Y29D

0.26

75000

P9Y25D

2024-02-13 2034-02-13

0.26

50000

P8Y1M17D

0.26

50000

P9Y1M17D

2025-01-17 2035-01-17

0.50

588750

341250

P9Y18D

2025-07-29 2035-07-29

0.37

50000

P9Y6M29D

0.23

7425004

7177504

P6Y9M29D

0.21

6786254

6420629

P7Y7M9D

500000

217500

39207

178293

1230000

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">7.</td> <td>Commitments and Contingencies Indemnification Agreements</td></tr> </table> In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners, and other parties with respect to certain matters. In addition, the Company has entered into indemnification agreements with members of its board of directors that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company does not believe that the outcome of any claims under indemnification arrangements will have a material effect on its consolidated financial position, results of operations, or cash flows, and it has not accrued any liabilities related to such obligations in its consolidated financial statements as of December 31, 2025, and December 31, 2024. Litigation From time to time, the Company may be subject to claims and lawsuits arising in the normal course of business. The Company’s management believes that the outcome of any litigation or claims will not have a material effect on the Company’s consolidated financial position, results of operations, or cash flows. As of December 31, 2025, management was not aware of any material active, pending, or threatened litigation.

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">8.</td> <td>Income Taxes</td></tr> </table> The Company provides for income taxes under ASC 740, “Income Taxes.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recorded based on the differences between the financial statement tax basis of assets and liabilities and the tax rates in effect when these differences are expected to reverse. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. <table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zqucyOOsROQg" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Tax expense)"> <tr style="vertical-align: bottom; background-color: white"> <td> Schedule of income tax expense</td> <td> </td> <td id="xdx_49A_20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_zHlEnzPPNxVc" style="text-align: center"> </td> <td> </td> <td> </td> <td id="xdx_496_20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaltumMember_zFl3tajE88Ul" style="text-align: center"> </td> <td> </td> <td> </td> <td id="xdx_494_20250101__20251231_zAmXEi8btDT3" style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td id="xdx_49F_20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_zjidWt9ychO1" style="text-align: center"> </td> <td> </td> <td> </td> <td id="xdx_49A_20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaltumMember_zOKEKmTjbhUh" style="text-align: center"> </td> <td> </td> <td> </td> <td id="xdx_497_20240101__20241231_zPbylFSvNF01" style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Rate Reconciliation</td> <td colspan="11" style="border-bottom: black 1pt solid; text-align: center">December 31, 2025</td> <td> </td> <td colspan="11" style="border-bottom: black 1pt solid; text-align: center">December 31, 2024</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Chilean Cobalt</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Baltum</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Consolidated</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Rate Impact</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Chilean Cobalt</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Baltum</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Consolidated</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Rate Impact</td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkDd67JRtCX" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 20%">Pre-tax book loss</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(1,053,324</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(2,209,816</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(3,263,140</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(785,031</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(97,543</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(882,574</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Federal rate</td> <td> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_z8uSIE3nvxRa" title="Federal income tax rate">21%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaltumMember_zbDG2IK8cWb5" title="Federal income tax rate">27%</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_z4qFuyT16TM4" title="Federal income tax rate">21%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaltumMember_z1yDycg1rwPa" title="Federal income tax rate">27%</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--CurrentFederalTaxExpenseBenefit_z0EelnexG7Ve" style="vertical-align: bottom; background-color: white"> <td>Federal provision</td> <td> </td> <td style="text-align: right">(221,000</td> <td>)</td> <td> </td> <td style="text-align: right">(597,000</td> <td>)</td> <td> </td> <td style="text-align: right">(818,000</td> <td>)</td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right">(165,000</td> <td>)</td> <td> </td> <td style="text-align: right">(27,000</td> <td>)</td> <td> </td> <td style="text-align: right">(192,000</td> <td>)</td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>State rate</td> <td> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_zBOvAt4U7zB8" title="State income tax rate">6.99%</td> <td> </td> <td> </td> <td style="text-align: right"> n/a </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_zaOJjlhXl97i" title="State income tax rate">6.99%</td> <td> </td> <td> </td> <td style="text-align: right"> n/a </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_405_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_d0_zoTGM9ftiIr8" style="vertical-align: bottom; background-color: #EEEEEE"> <td>State provision</td> <td> </td> <td style="text-align: right">(74,000</td> <td>)</td> <td> </td> <td style="text-align: right">–</td> <td> </td> <td> </td> <td style="text-align: right">(74,000</td> <td>)</td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right">(55,000</td> <td>)</td> <td> </td> <td style="text-align: right">–</td> <td> </td> <td> </td> <td style="text-align: right">(55,000</td> <td>)</td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_z8oTjNr0McF7" style="vertical-align: bottom; background-color: #EEEEEE"> <td>Provision at statutory rate</td> <td> </td> <td style="text-align: right">(295,000</td> <td>)</td> <td> </td> <td style="text-align: right">(597,000</td> <td>)</td> <td> </td> <td style="text-align: right">(892,000</td> <td>)</td> <td> </td> <td style="text-align: right">27%</td> <td> </td> <td> </td> <td style="text-align: right">(220,000</td> <td>)</td> <td> </td> <td style="text-align: right">(27,000</td> <td>)</td> <td> </td> <td style="text-align: right">(247,000</td> <td>)</td> <td> </td> <td style="text-align: right">28%</td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zZsfvfhYze2" style="vertical-align: bottom; background-color: white"> <td>Change in valuation allowance</td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">295,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">597,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">892,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">-27%</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">220,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">27,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">247,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">-28%</td> <td> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_d0_zTet7b1YsG47" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt">Total tax expense (benefit) current and deferred</td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">0%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">0%</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> As of December 31, 2025, the Company had federal and state net operating loss carryforwards of approximately $6,900,000 with no expiration date to use these credits, that are available to offset future liabilities for income taxes. The Company paid no income taxes in the years ended December 31, 2025, and December 31, 2024 in any jurisdiction, related to returns for the fiscal years ended December 31, 2024, and December 31, 2023, nor does it expect to pay any income taxes in 2026, related to the return for the fiscal year ended December 31, 2025. The Company has generally established a valuation allowance against these carryforwards based on an assessment that it is more likely than not that these benefits will not be realized in future years. The Company has reviewed the scheduled reversals of the deferred tax assets and its projected taxable income in conjunction with the changes in tax laws enacted and determined a valuation allowance is required at December 31, 2025 and 2024. The December 31, 2025 and 2024, results of operations include an increase in our valuation allowance of $892,000 and $247,000, respectively. We established the valuation allowance based on the weight of available evidence, both positive and negative, including results of recent and current operations and our estimates of future taxable income or loss by jurisdiction in which we operate. In order to determine the amount of deferred tax assets or liabilities, as well as the valuation allowances, we must make assumptions, including changes in tax laws and other changes impacting our ability to recognize the underlying deferred tax assets, could require us to adjust the valuation allowances. The Company has not undertaken a formal analysis of 26 C.F.R. Section 382 and cannot determine at this time whether the NOL will be subject to limitations due to a change in control.

<table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zqucyOOsROQg" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Tax expense)"> <tr style="vertical-align: bottom; background-color: white"> <td> Schedule of income tax expense</td> <td> </td> <td id="xdx_49A_20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_zHlEnzPPNxVc" style="text-align: center"> </td> <td> </td> <td> </td> <td id="xdx_496_20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaltumMember_zFl3tajE88Ul" style="text-align: center"> </td> <td> </td> <td> </td> <td id="xdx_494_20250101__20251231_zAmXEi8btDT3" style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td id="xdx_49F_20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_zjidWt9ychO1" style="text-align: center"> </td> <td> </td> <td> </td> <td id="xdx_49A_20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaltumMember_zOKEKmTjbhUh" style="text-align: center"> </td> <td> </td> <td> </td> <td id="xdx_497_20240101__20241231_zPbylFSvNF01" style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Rate Reconciliation</td> <td colspan="11" style="border-bottom: black 1pt solid; text-align: center">December 31, 2025</td> <td> </td> <td colspan="11" style="border-bottom: black 1pt solid; text-align: center">December 31, 2024</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Chilean Cobalt</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Baltum</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Consolidated</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Rate Impact</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Chilean Cobalt</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Baltum</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Consolidated</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Rate Impact</td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zkDd67JRtCX" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 20%">Pre-tax book loss</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(1,053,324</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(2,209,816</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(3,263,140</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(785,031</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(97,543</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(882,574</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Federal rate</td> <td> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_z8uSIE3nvxRa" title="Federal income tax rate">21%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaltumMember_zbDG2IK8cWb5" title="Federal income tax rate">27%</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_z4qFuyT16TM4" title="Federal income tax rate">21%</td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaltumMember_z1yDycg1rwPa" title="Federal income tax rate">27%</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--CurrentFederalTaxExpenseBenefit_z0EelnexG7Ve" style="vertical-align: bottom; background-color: white"> <td>Federal provision</td> <td> </td> <td style="text-align: right">(221,000</td> <td>)</td> <td> </td> <td style="text-align: right">(597,000</td> <td>)</td> <td> </td> <td style="text-align: right">(818,000</td> <td>)</td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right">(165,000</td> <td>)</td> <td> </td> <td style="text-align: right">(27,000</td> <td>)</td> <td> </td> <td style="text-align: right">(192,000</td> <td>)</td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>State rate</td> <td> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_zBOvAt4U7zB8" title="State income tax rate">6.99%</td> <td> </td> <td> </td> <td style="text-align: right"> n/a </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChileanCobaltMember_zaOJjlhXl97i" title="State income tax rate">6.99%</td> <td> </td> <td> </td> <td style="text-align: right"> n/a </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_405_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_d0_zoTGM9ftiIr8" style="vertical-align: bottom; background-color: #EEEEEE"> <td>State provision</td> <td> </td> <td style="text-align: right">(74,000</td> <td>)</td> <td> </td> <td style="text-align: right">–</td> <td> </td> <td> </td> <td style="text-align: right">(74,000</td> <td>)</td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right">(55,000</td> <td>)</td> <td> </td> <td style="text-align: right">–</td> <td> </td> <td> </td> <td style="text-align: right">(55,000</td> <td>)</td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_z8oTjNr0McF7" style="vertical-align: bottom; background-color: #EEEEEE"> <td>Provision at statutory rate</td> <td> </td> <td style="text-align: right">(295,000</td> <td>)</td> <td> </td> <td style="text-align: right">(597,000</td> <td>)</td> <td> </td> <td style="text-align: right">(892,000</td> <td>)</td> <td> </td> <td style="text-align: right">27%</td> <td> </td> <td> </td> <td style="text-align: right">(220,000</td> <td>)</td> <td> </td> <td style="text-align: right">(27,000</td> <td>)</td> <td> </td> <td style="text-align: right">(247,000</td> <td>)</td> <td> </td> <td style="text-align: right">28%</td> <td> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zZsfvfhYze2" style="vertical-align: bottom; background-color: white"> <td>Change in valuation allowance</td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">295,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">597,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">892,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">-27%</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">220,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">27,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">247,000</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">-28%</td> <td> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_d0_zTet7b1YsG47" style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt">Total tax expense (benefit) current and deferred</td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">0%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">–</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">0%</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

-1053324

-2209816

-3263140

-785031

-97543

-882574

0.21

0.27

0.21

0.27

-221000

-597000

-818000

-165000

-27000

-192000

0.0699

-74000

-55000

-295000

-597000

-892000

0.27

-220000

-27000

-247000

0.28

295000

597000

892000

220000

27000

247000

6900000

892000

247000

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">9.</td> <td>Related Party Activity</td></tr> </table> The Company’s Chilean legal counsel, Quinzio Abogados SpA (“QA”) have power of attorney (“POA”) over and also provide legal counsel to Baltum. Baltum’s contracted general manager is Felipe Quinzio, the sole owner of NyD Mining SpA (“NyD”). Baltum paid NyD for the services of Felipe Quinzio during the years ended December 31, 2025 and December 31, 2024 and for accounting services provided by NyD since July 2024. One of the law partners and owner of QA is Cristian Quinzio, who is the parent of Felipe Quinzio. Baltum pays QA for legal services provided, whether QA is engaged at the request of Baltum or the Company. There were no bills outstanding with Baltum to NyD at December 31, 2025 or December 31, 2024. There were bills for $1,401 and $-0- outstanding with Baltum to QA at December 31, 2025 and December 31, 2024, respectively. There were no amounts accrued for legal services or managerial and accounting services accrued for either QA or NyD at December 31, 2025 or December 31, 2024. Baltum incurred legal expenses provided by QA of $40,402 and $6,568 for the years ended December 31, 2025 and December 31, 2024, respectively. Baltum incurred managerial and accounting expenses provided by NyD of $40,784 and $35,098 for the years ended December 31, 2025 and December 31, 2024, respectively. In addition, Baltum made no direct reimbursements to Felipe Quinzio for business expenses paid by him in the years ended December 31, 2025 and December 31, 2024, respectively. The Company’s director, Ash Lazenby, has an advisory agreement with the Company and stands to receive 500,000 RSU’s when they vest in July 2027, which have an intrinsic value of $<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_iI_c20251231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AshLazenbyMember_zYTQJQE6Fzff" title="Intrinsic value of unvested RSU's">1,230,000 as of December 31, 2025. Also, Mr. Lazenby is a former employee of Glencore Ltd. Glencore Ltd is an investor in the Company and has a Deed of Undertaking with the Company giving it first and last right of refusal on cobalt and copper off-take from any future production at the Company’s La Cobaltera and El Cofre Projects for the life of mine.

1230000

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">10.</td> <td>Subsequent Events</td></tr> </table> Subsequent to year-end, on January 6, 2026, CORFO (the Chilean Economic Development Agency) officially announced the selection of the project entitled “Sustainable Cobalt: A Semi-Industrial Validation of the Green Cobalt Biotechnological Process Integrated with an Extractive Metallurgical Strategy Focused on Tailings and Circular Mining” (the “Project”) for a $3,000,000 R&D Contribution (the “Grant”), which is to be funded by Albemarle Limitada under agreement with CORFO to support research and development programs vetted and approved by CORFO. The Project objective is to recover marketable volumes of cobalt product from tailings and mining waste. The Company is one participant in a consortium of industry sponsors for the Project and has committed to providing $200,000 overall support consisting of half monetary and half in-kind support over the expected three-year project timeline. The Company’s support equates to approximately 21% of the overall consortium-required support contribution of $950,000 toward the project. The other key participants in the consortium are Universidad Andres Belo, through its Center for Systems Biotechnology, Pucobre (SSE: PUCOBRE), a Chilean copper mining company listed on the Santiago Stock Exchange, and ENAMI, Chile’s state-owned mining company. Subsequent to year-end, on January 8, 2026, the Company entered into a binding earn-in and option agreement with NeoRe SpA, a privately-held Chilean Company to acquire approximately 6,300 hectares of mining concessions (the “Properties”) within the coastal belt region near Concepcion Chile with an ionic adsorption clay-style rare earth elements system enriched with yttrium, neodymium, dysprosium and terbium elements critical to defense and advanced manufacturing supply chains. If the option to acquire the mining concessions for development contributions and 6,000,000 common shares of the Company is not exercised, the Company may still earn as much as a 2% net smelter return royalty (“NSR”) on the Properties, depending on the phase of project development achieved through funding by the Company, subject to a maximum of $3,000,000USD to be contributed over an expected nine to eighteen month expected scale-up period to production. Upon exercise of the option, a definitive agreement for the acquisition of the Properties would outline the conditions precedent, project management and environmental, social and governance commitments. The Company is not obligated to proceed with the earn-in contributions or the acquisition of the Properties if its ongoing due diligence or other strategic priorities dictate otherwise, however, any amounts contributed that do not go toward the earning of an additional NSR stake are non-refundable.

false false false false Award Timing Disclosure The Company’s board typically grants annual equity awards during scheduled meetings, independent of MNPI releases. Awards are not timed to coincide with MNPI, and the Company did not intentionally align MNPI releases to influence compensation during the years ended December 31, 2025, and December 31, 2024. <div class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_98E_eecd--AwardsCloseToMnpiDiscTableTextBlock_c20250101__20251231_zMPP5Dt0l3N6"> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Securities Underlying Options (Shares)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price (per Share)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date Fair Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% Change in Closing Price (1)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 27%; text-align: left"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--AwardsCloseToMnpiDiscIndName_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_fKDIp_z836G1Wr66se">Duncan Blount (PEO)</td><td style="width: 2%"> </td> <td style="width: 17%; text-align: center">January 17, 2025</td><td style="width: 2%"> </td> <td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_985_eecd--AwardUndrlygSecuritiesAmt_iI_uShares_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_fKDIp_zqZTPkZ4VXgb" style="width: 11%; text-align: right">200,000</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_984_eecd--AwardExrcPrice_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_fKDIp_zOZb0l772Bza" style="width: 11%; text-align: right">0.50</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--AwardGrantDateFairValue_iI_pp2p0_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_z6b55KnJ5TD">80,398</td><td style="width: 2%"> </td> <td style="width: 11%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_903_eecd--UndrlygSecurityMktPriceChngPct_iI_dp_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_fKDEp_zptoJTpyRgv5">0%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_900_eecd--AwardsCloseToMnpiDiscIndName_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_fKDIp_z6ZFK1mcJK44">Jim Van Horn (CFO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_986_eecd--AwardUndrlygSecuritiesAmt_iI_uShares_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_fKDIp_z1uFSt2xvBOj" style="text-align: right">60,000</td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_985_eecd--AwardExrcPrice_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_fKDIp_zlxEtwCSJzLf" style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_901_eecd--AwardGrantDateFairValue_iI_pp2p0_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_zAUqjoyyGo8j">24,119</td><td> </td> <td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--UndrlygSecurityMktPriceChngPct_iI_dp_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_fKDEp_zsrTwaisbxJj">0%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--AwardsCloseToMnpiDiscIndName_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_fKDIp_zh2eFKSIIQ7i">Jeremy McCann (COO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_981_eecd--AwardUndrlygSecuritiesAmt_iI_uShares_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_fKDIp_zXLb1Hc5xpC9" style="text-align: right">25,000</td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_98F_eecd--AwardExrcPrice_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_fKDIp_zHC4Bt8R9Ijk" style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--AwardGrantDateFairValue_iI_pp2p0_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_z6xHszp0X8V9">10,050</td><td> </td> <td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--UndrlygSecurityMktPriceChngPct_iI_dp_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_fKDEp_zPXL5hUaTTDa">0%</td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 3%">(1)</td> <td id="xdx_F17_z8aRMutGHKml" style="text-align: justify; width: 97%">For the award on January 17, 2025, there were two covered periods that were triggered related to a Form 8-K filing on January 16, 2025 and another Form 8-K filing on January 22, 2025, the % change in closing price is zero (0%) for both periods.</td></tr> </table> </div> false <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Securities Underlying Options (Shares)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price (per Share)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date Fair Value</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% Change in Closing Price (1)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 27%; text-align: left"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--AwardsCloseToMnpiDiscIndName_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_fKDIp_z836G1Wr66se">Duncan Blount (PEO)</td><td style="width: 2%"> </td> <td style="width: 17%; text-align: center">January 17, 2025</td><td style="width: 2%"> </td> <td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_985_eecd--AwardUndrlygSecuritiesAmt_iI_uShares_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_fKDIp_zqZTPkZ4VXgb" style="width: 11%; text-align: right">200,000</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_984_eecd--AwardExrcPrice_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_fKDIp_zOZb0l772Bza" style="width: 11%; text-align: right">0.50</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_902_eecd--AwardGrantDateFairValue_iI_pp2p0_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_z6b55KnJ5TD">80,398</td><td style="width: 2%"> </td> <td style="width: 11%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_903_eecd--UndrlygSecurityMktPriceChngPct_iI_dp_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--DuncanBlountMember_fKDEp_zptoJTpyRgv5">0%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_900_eecd--AwardsCloseToMnpiDiscIndName_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_fKDIp_z6ZFK1mcJK44">Jim Van Horn (CFO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_986_eecd--AwardUndrlygSecuritiesAmt_iI_uShares_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_fKDIp_z1uFSt2xvBOj" style="text-align: right">60,000</td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_985_eecd--AwardExrcPrice_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_fKDIp_zlxEtwCSJzLf" style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_901_eecd--AwardGrantDateFairValue_iI_pp2p0_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_zAUqjoyyGo8j">24,119</td><td> </td> <td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_908_eecd--UndrlygSecurityMktPriceChngPct_iI_dp_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JimVanHornMember_fKDEp_zsrTwaisbxJj">0%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--AwardsCloseToMnpiDiscIndName_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_fKDIp_zh2eFKSIIQ7i">Jeremy McCann (COO)</td><td> </td> <td style="text-align: center">January 17, 2025</td><td> </td> <td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_981_eecd--AwardUndrlygSecuritiesAmt_iI_uShares_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_fKDIp_zXLb1Hc5xpC9" style="text-align: right">25,000</td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_98F_eecd--AwardExrcPrice_iI_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_fKDIp_zHC4Bt8R9Ijk" style="text-align: right">0.50</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--AwardGrantDateFairValue_iI_pp2p0_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_z6xHszp0X8V9">10,050</td><td> </td> <td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--UndrlygSecurityMktPriceChngPct_iI_dp_c20250507__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__ecd--IndividualAxis__custom--JeremyMcCannMember_fKDEp_zPXL5hUaTTDa">0%</td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 3%">(1)</td> <td id="xdx_F17_z8aRMutGHKml" style="text-align: justify; width: 97%">For the award on January 17, 2025, there were two covered periods that were triggered related to a Form 8-K filing on January 16, 2025 and another Form 8-K filing on January 22, 2025, the % change in closing price is zero (0%) for both periods.</td></tr> </table> Duncan Blount 200000 0.50 80398 0 Jim Van Horn 60000 0.50 24119 0 Jeremy McCann 25000 0.50 10050 0 true At the time of determination of expected stock volatility, the Company’s securities were trading over-the-counter as an OTCQB traded stock, but for less than two years and under limited trading volume such that calculated volatility based solely on the Company’s volatility isn’t necessarily indicative of the expected volatility over the expected life of the options and RSUs. Therefore, the expected stock volatility was estimated using three public companies in the same industry as the Company and calculating an equal-weighted and blended volatility of the Company’s volatility and the volatility of those three believed-to-be-representative companies over the same period. For the award on January 17, 2025, there were two covered periods that were triggered related to a Form 8-K filing on January 16, 2025 and another Form 8-K filing on January 22, 2025, the % change in closing price is zero (0%) for both periods.